0001493152-24-009931.txt : 20240314 0001493152-24-009931.hdr.sgml : 20240314 20240314141812 ACCESSION NUMBER: 0001493152-24-009931 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240314 DATE AS OF CHANGE: 20240314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hartford Great Health Corp. CENTRAL INDEX KEY: 0001482554 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology IRS NUMBER: 205422795 STATE OF INCORPORATION: NV FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54439 FILM NUMBER: 24749136 BUSINESS ADDRESS: STREET 1: 8832 GLENDON WAY CITY: ROSEMEAD STATE: CA ZIP: 91770 BUSINESS PHONE: 626-656-6192 MAIL ADDRESS: STREET 1: 8832 GLENDON WAY CITY: ROSEMEAD STATE: CA ZIP: 91770 FORMER COMPANY: FORMER CONFORMED NAME: Photoamigo, Inc. DATE OF NAME CHANGE: 20100128 10-Q 1 form10-q.htm
false --07-31 Q2 0001482554 0001482554 2023-08-01 2024-01-31 0001482554 2024-03-14 0001482554 2024-01-31 0001482554 2023-07-31 0001482554 us-gaap:RelatedPartyMember 2024-01-31 0001482554 us-gaap:RelatedPartyMember 2023-07-31 0001482554 2023-11-01 2024-01-31 0001482554 2022-11-01 2023-01-31 0001482554 2022-08-01 2023-01-31 0001482554 us-gaap:CommonStockMember 2023-07-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001482554 us-gaap:RetainedEarningsMember 2023-07-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-07-31 0001482554 us-gaap:CommonStockMember 2023-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001482554 us-gaap:RetainedEarningsMember 2023-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-10-31 0001482554 2023-10-31 0001482554 us-gaap:CommonStockMember 2022-07-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001482554 us-gaap:RetainedEarningsMember 2022-07-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-31 0001482554 us-gaap:NoncontrollingInterestMember 2022-07-31 0001482554 2022-07-31 0001482554 us-gaap:CommonStockMember 2022-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001482554 us-gaap:RetainedEarningsMember 2022-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2022-10-31 0001482554 2022-10-31 0001482554 us-gaap:CommonStockMember 2023-08-01 2023-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-08-01 2023-10-31 0001482554 us-gaap:RetainedEarningsMember 2023-08-01 2023-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-08-01 2023-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-08-01 2023-10-31 0001482554 2023-08-01 2023-10-31 0001482554 us-gaap:CommonStockMember 2023-11-01 2024-01-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-11-01 2024-01-31 0001482554 us-gaap:RetainedEarningsMember 2023-11-01 2024-01-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-11-01 2024-01-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-11-01 2024-01-31 0001482554 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001482554 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-08-01 2022-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2022-08-01 2022-10-31 0001482554 2022-08-01 2022-10-31 0001482554 us-gaap:CommonStockMember 2022-11-01 2023-01-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-01-31 0001482554 us-gaap:RetainedEarningsMember 2022-11-01 2023-01-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-11-01 2023-01-31 0001482554 us-gaap:NoncontrollingInterestMember 2022-11-01 2023-01-31 0001482554 us-gaap:CommonStockMember 2024-01-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0001482554 us-gaap:RetainedEarningsMember 2024-01-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-31 0001482554 us-gaap:NoncontrollingInterestMember 2024-01-31 0001482554 us-gaap:CommonStockMember 2023-01-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001482554 us-gaap:RetainedEarningsMember 2023-01-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-01-31 0001482554 2023-01-31 0001482554 HFUS:HangzhouLongjingQiaoFuVacationHotelCoLtdMember 2020-12-31 0001482554 HFUS:ShanghaiQiaoGardenInternationalTravelAgencyMember 2020-12-31 0001482554 HFUS:ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember 2019-07-24 0001482554 HFUS:ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember 2020-03-23 0001482554 HFUS:ShanghaiHdfdZhongliEducationTechnologyCoLtdMember 2021-08-31 0001482554 HFUS:TwoIndividualInvestorsMember 2021-08-31 0001482554 HFUS:ShanghaiOverseaMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2022-08-01 0001482554 HFUS:ShanghaiOverseaMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2022-08-01 0001482554 HFUS:ShanghaiOverseaMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:HangzhouHartfordComprehensiveHealthManagementLtdMember 2022-08-01 0001482554 HFUS:ShanghaiOverseaMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:HangzhouHartfordComprehensiveHealthManagementLtdMember 2022-08-01 0001482554 HFUS:ShanghaiDubianAssetsManagementLtdMember 2023-08-01 2024-01-31 0001482554 HFUS:ShanghaiLuoShengInternationalTradeLtdMember 2019-01-31 0001482554 HFUS:ShanghaiLuoShengInternationalTradeLtdMember 2022-08-01 0001482554 HFUS:ShanghaiOverseaMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-08-01 0001482554 HFUS:ShanghaiOverseaMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-08-01 2022-08-01 0001482554 HFUS:SHQiahongMember 2024-01-31 0001482554 HFUS:SHQiahongMember 2023-07-31 0001482554 HFUS:ShanghaiOverseaChineseCultureMediaLtdMember 2024-01-31 0001482554 HFUS:ShanghaiOverseaChineseCultureMediaLtdMember 2023-07-31 0001482554 HFUS:HartfordHotelInvestmentIncMember 2024-01-31 0001482554 us-gaap:SubsequentEventMember HFUS:MRLianyuSongMember 2024-02-22 2024-02-23 0001482554 HFUS:MRLianyuSongMember us-gaap:SubsequentEventMember 2024-02-23 0001482554 HFUS:HartfordHotelInvestmentIncMember us-gaap:SubsequentEventMember 2024-03-01 2024-03-01 0001482554 us-gaap:SubsequentEventMember 2024-02-01 2024-02-29 0001482554 us-gaap:SubsequentEventMember 2024-02-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CNY

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF

 

1934 For the quarterly period ended: January 31, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
   
  EXCHANGE ACT For the transition period from ________ to ________

 

Commission File Number: 000-54439

 

HARTFORD GREAT HEALTH CORP.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada

(State or other jurisdiction of incorporation or organization)

 

51-0675116

(I.R.S. Employer Identification Number)

 

8832 Glendon Way, Rosemead, California 91770

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number including area code: (626)321-1915

 

 

Former name, former address, and former fiscal year, if changed since last report

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by checkmark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☒
Emerging growth company ☒  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.001 par value   HFUS   OTC Markets Group

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 100,108,000 shares of common stock outstanding as of March 14, 2024.

 

 

 

 

 

 

Index
     
  Page
Part I - FINANCIAL INFORMATION  
     
Item 1. Unaudited Consolidated Financial Statements  
  Condensed Consolidated Balance Sheets as of January 31, 2024 (unaudited) and July 31, 2023 3
  Condensed Consolidated Statements of Operations for the Three and Six months ended January 31, 2024 and 2023 (unaudited) 4
  Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Six months ended January 31, 2024 and 2023 (unaudited) 5
  Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (unaudited) 6
  Condensed Consolidated Statements of Cash Flows for the Six months ended January 31, 2024 and 2023 (unaudited) 7
  Notes to Condensed Consolidated Financial Statements (unaudited) 8
     
Item 2. Management’s Discussion and Analysis or Plan of Operation 12
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 15
     
Item 4. Controls and Procedures 15
     
Part II - OTHER INFORMATION 16
     
Item 1. Legal Proceedings 16
     
Item 1A. Risk Factors 16
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 16
     
Item 3. Defaults Upon Senior Securities 16
     
Item 4. Mine Safety Disclosures 16
     
Item 5. Other Information 16
     
Item 6. Exhibits 16
     
SIGNATURES 17

 

2

 

 

HARTFORD GREAT HEALTH CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   January 31, 2024   July 31, 2023 
   (Unaudited)     
ASSETS          
Current Assets          
Cash and cash equivalents  $8,484   $5,793 
Prepaid and Other current receivables   282    280 
Related party receivable   964    964 
Total Current Assets   9,730    7,037 
Non-current Assets          
Property and equipment, net   597    730 
Total Non-current Assets   597    730 
TOTAL ASSETS  $10,327   $7,767 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities          
Related party loan and payables  $4,440,337   $4,367,194 
Other current payable   131,835    130,279 
Total Current Liabilities   4,572,172    4,497,473 
TOTAL LIABILITIES   4,572,172    4,497,473 
Commitments and contingencies   -    - 
Stockholders’ Equity (Deficit)          
Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding   -    - 
Common stock - $0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of January 31, 2024 and July 31, 2023.   100,108    100,108 
Additional paid-in capital   2,173,521    2,173,521 
Accumulated deficit   (7,049,170)   (7,003,717)
Accumulated other comprehensive income   213,696    240,382 
Total Stockholders’ Deficit   (4,561,845)   (4,489,706)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $10,327   $7,767 

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

3

 

 

HARTFORD GREAT HEALTH CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

   2024   2023   2024   2023 
   Three months ended   Six months ended 
   January 31,   January 31, 
   2024   2023   2024   2023 
Revenue - Related Party  $62,443   $-   $62,443   $- 
Cost of revenue - Related Party   55,505    -    55,505    - 
Gross Profit   6,938    -    6,938    - 
Operating expenses                    
Selling, general and administrative   21,942    21,362    42,134    76,010 
Total operating expenses   21,942    21,362    42,134    76,010 
Operating Loss   (15,004)   (21,362)   (35,196)   (76,010)
Other Income (Expense)                    
Interest (expense), net   (5,067)   (4,089)   (10,331)   (8,178)
Gain on disposal of subsidiary   -    -    -    539,230 
Other income (expense), net   74    -    74    (91)
Other income (expense), net   (4,993)   (4,089)   (10,257)   530,961 
(Loss) income before income taxes   (19,997)   (25,451)   (45,453)   454,951 
Income Tax Expense   -    -    -    - 
Net (loss) income   (19,997)   (25,451)   (45,453)   454,951 
                     
Net (loss) income per common share:         
Basic and diluted  $(0.00)  $(0.00)  $(0.00)  $0.00 
Weighted average shares outstanding:                    
Basic and diluted   100,108,000    100,108,000    100,108,000    100,108,000 

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

4

 

 

HARTFORD GREAT HEALTH CORP.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

 

   2024   2023   2024   2023 
   Three months ended   Six months ended 
   January 31,   January 31, 
   2024   2023   2024   2023 
Net (loss) income  $(19,997)  $(25,451)  $(45,453)  $454,951 
Other Comprehensive (loss) income, net of income tax                    
Foreign currency translation adjustments   (123,853)   (322,644)   (26,686)   23,289 
Total other comprehensive (loss) income   (123,853)   (322,644)   (26,686)   23,289 
Total Comprehensive (loss) income  $(143,850)  $(348,095)  $(72,139)  $478,240 

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

5

 

 

HARTFORD GREAT HEALTH CORP.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

 

                         
                   Accumulated   Total 
           Additional       Other   Stockholders’ 
   Common Stock   Paid - in   Accumulated   Comprehensive   Equity 
   Shares   Amount   Capital   (Deficit)   income   (Deficit) 
Balance, July 31, 2023   100,108,000    100,108    2,173,521    (7,003,717)   240,382 -  (4,489,706)
Net loss   -    -    -    (25,456)   - -  (25,456)
Foreign currency translation adjustment   -    -    -    -    97,167 -  97,167 
Balance, October 31, 2023 (unaudited)   100,108,000    100,108    2,173,521    (7,029,173)   337,549 -  (4,417,995)
Net loss   -    -    -    (19,997)   - -  (19,997)
Foreign currency translation adjustment   -    -    -    -    (123,853)   (123,853)
Balance, January 31, 2024 (unaudited)   100,108,000    100,108    2,173,521    (7,049,170)   213,696 -  (4,561,845)

 

                                    
                   Accumulated       Total 
           Additional       Other       Stockholders’ 
   Common Stock   Paid - in   Accumulated   Comprehensive   Noncontrolling   Equity 
   Shares   Amount   Capital   (Deficit)   (loss) income   Interest   (Deficit) 
Balance, July 31, 2022   100,108,000    100,108    2,173,521    (7,400,620)   (16,742)   (1,288,916)   (6,432,649)
Net income   -    -    -    480,402              480,402 
Disposal of subsidiary                           1,307,586    1,307,586 
Foreign currency translation adjustment                       345,933    (18,670)   327,263 
Balance, October 31, 2022 (unaudited)   100,108,000    100,108    2,173,521    (6,920,218)   329,191    -    (4,317,398)
Net income   -    -    -    (25,451)   -    -    (25,451)
Foreign currency translation adjustment   -    -    -    -    (322,644)   -    (322,644)
Balance, January 31, 2023 (unaudited)   100,108,000    100,108    2,173,521    (6,945,669)   6,547    -    (4,665,493)

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

6

 

 

HARTFORD GREAT HEALTH CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

   2024   2023 
   Six months ended 
   January 31, 
   2024   2023 
Cash flows from operating activities:          
Net (loss) income  $(45,453)  $454,951 
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Depreciation   136    - 
Disposal of subsidiaries   -    (539,230)
Changes in operating assets and liabilities:          
Prepaid and Other current receivables   -    827 
Related party receivables and payables   10,330    26,955 
Other current payable   694    (6,631)
Net cash used in operating activities   (34,293)   (63,128)
           
Cash flows from investing activities:          
Net cash used in investing activities   -    - 
           
Cash flows from financing activities:          
Proceeds of related party notes payable   36,000    60,000 
Advances from related parties   971    - 
Net cash provided by financing activities   36,971    60,000 
Effect of exchange rate changes on cash   13    (1,524)
Net change in Cash, cash equivalents and restricted cash   2,691    (4,652)
Cash, cash equivalents and restricted cash at beginning of period   5,793    15,227 
Cash, cash equivalents and restricted cash at end of period  $8,484   $10,575 
           
Supplemental Cash Flow Information          
Interest paid  $-   $- 
Income taxes paid  $-   $- 

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

7

 

 

HARTFORD GREAT HEALTH CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. The financial statements and notes are the responsibility of the Company’s management. These accounting policies conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied in the preparation of the financial statements. This disclosure should be read in conjunction with our audited financial statements for the year ended July 31, 2023, including footnotes, contained in our Annual Report on Form 10-K.

 

Organization

 

Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.

 

Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s 60 percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Health Management, Ltd. (“HFSH”) and its 90 percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020.

 

The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two 100% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”). Gelinke temporally ceased its operations by the end of August 2021. On August 31, 2021, PDHJ established one 96% owned subsidiary, Shanghai HDFD Zhongli Education Technology Co., Ltd. (“Zhongli”), two individual investors hold the remaining 4% ownership.

 

Impacted by the government regulation implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, to avoid further operation losses, on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell 90 percent ownership of HF Int’l Education and its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell 100 percent ownership of HZHF and its subsidiaries for $1,000 (RMB 6,500). See Note 3 Acquisitions and Disposals.

 

On January 10, 2024, HFSH changed its legal name from Shanghai Hartford Health Management, Ltd. to Hartford ZY Culture Media (Shanghai) Co., Ltd., hereon refer to as “HFZY”. and started to deliver media and advertisement services. HFZY mainly engage in social media advertising business on mainstream social media platforms such as Tik Tok, Toutiao, Kwai, RED, WeChat, and more. As an advertising partner of China’s major social media platforms, it provides customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. HFZY is one of the total solution advertising providers for domestic social media industry in China.

 

Basis of Presentation

 

The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

8

 

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.

 

Revenue Recognition

 

The Company follows the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms.

 

The Company is developing business plan to provide customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. Most of the advertising revenue will be generated by placing ad products on Tik Tok, Toutiao, Kwai, RED, WeChat, and other third-party affiliated websites and mobile applications. The revenues from the display of impression-based ads will be recognized in the contracted period in which the impressions are delivered. The Company will also generate revenue from the delivery of certain services, such as the creation and delivery of ads that appear on third-party publishers’ websites and social platforms. The Company recognizes revenues from these services in the period in which the service is completed. During current reporting period, the Company generated $62,443 revenue from designing, making, and placing video advertising for our related party customers, primarily Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives.

 

In the past years, the company’s main operations were focusing on Early childhood education services and Hospitality services. Impacted by the Covid-19 pandemic and Chinese regulation on education industry, both early childhood education services and hospitality services have been sold on August 1 2022. Thus, there was no revenue recognized for the three and six months ended January 31, 2023. See Note 3 Acquisitions and Disposals.

 

Recent Accounting Pronouncements.

 

Recently not yet adopted accounting pronouncements

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new guidance requires enhanced disclosures about income tax expenses. The Company is required to adopt this guidance in the first quarter of the fiscal year 2026. Early adoption is permitted on a prospective basis. We are currently evaluating the impact of this ASU on our annual income tax disclosures.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new guidance requires enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for its annual reporting in fiscal year 2025 and for interim period reporting beginning the first quarter of fiscal year 2026 on a retrospective basis. Early adoption is permitted. We are currently evaluating the impact of this ASU on our segment disclosures.

 

The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

 

9

 

 

NOTE 2. GOING CONCERN

 

The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, Hartford Great Health Corp. has incurred losses since inception, resulting in an accumulated deficit of $7,049,170 as of January 31, 2024. This condition  raises substantial doubt about the ability of Hartford Great Health Corp. to continue as a going concern.

 

In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to Hartford Great Health Corp., and ultimately achieving profitable operations. Management believes that Hartford Great Health Corp.’s business plan provides it with an opportunity to continue as a going concern. However, management cannot provide assurance that Hartford Great Health Corp. will meet its objectives and be able to continue in operation.

 

The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of Hartford Great Health Corp. to continue as a going concern.

 

NOTE 3. ACQUISITIONS AND DISPOSALS

 

In January 2019, HFSH entered agreements to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). On August 1, 2022, HFSH decided to withdraw from the agreement entered in January 2019 to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). There was no penalty levied or to be levied due to delayed execution or inexecution.

 

Impacted by the government regulation newly implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, the Company’s business hasn’t been developed as planned and occurred significant loss from the early child education practice. To avoid further operation losses, subsequently on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell 90 percent ownership of HF Int’l Education and its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell 100 percent ownership of HZHF and its subsidiaries for $1,000 (RMB 6,500).

SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY

Net assets (liabilities) disposed of:    
     
Cash and cash equivalents  $4,938 
Prepaid and Other current receivables   45,532 
Related party receivable   428,519 
Inventory   305,124 
Property and equipment - Net   582,707 
ROU assets-Operating lease   2,836,698 
Other assets   296,218 
Related party loan and payables   (1,321,549)
Contract liabilities   (547,906)
Lease liabilities, current and noncurrent   (3,715,688)
Other current payable   (401,782)
Other liabilities   (357,796)
Noncontrolling interest   1,307,586 
Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest   (537,399)
Consideration   1,831 
Gain on disposal of the subsidiaries  $(539,230)

 

10

 

 

NOTE 4. RELATED PARTY TRANSACTIONS

 

Related Party Receivables

 

HFUS had $964 related party receivable as of both January 31, 2024 and July 31, 2023, due from SH Oversea in relation to the disposal consideration.

 

Related Party Payables and loans

 

As of January 31, 2024 and July 31, 2023, amounts of $582,601 and $586,236, respectively, are payable to SH Qiaohong. The balances were mainly funding support from SH Qiaohong for operation. The funding support bears no interest and due on demand.

 

HFSH had payable balances to Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), an entity previously was managed by the same management team, in the amounts of $3,321,300 and $3,291,324 as of January 31, 2024 and July 31, 2023, respectively. The payable is funding support from SH Oversea for operation, bears no interest and due on demand.

 

HFUS borrowed in form of a short-term loan at 5% per annum from a related party, Hartford Hotel Investment Inc., an entity managed by the same management team. $5,067 and $10,331 of interest expenses were recorded during the three and six months ended January 31, 2024, respectively. $4,089 and $8,178 of interest expenses were recorded during the three and six months ended January 31, 2023, respectively. As of January 31, 2024 and July 31, 2023, the unpaid principal and interest amount of $463,831 and $417,501, respectively, will be due on demand.

 

The remaining related party payable of $72,605 and $72,133 as of January 31, 2024 and July 31, 2023, respectively, represents the unpaid portion of operating advances made to the Company by its main shareholder, Mr. Lianyue Song. These advances do not bear interest and are considered due on demand.

 

Other Related Party Transactions

 

During the three and six months ended January 31, 2024, the Company generated $62,443 revenue from designing, making, and placing video advertising for its related parties, primarily Shanghai DuBian Assets Management Ltd., which is managed by the Company’s major shareholder’s relatives. For the three and six months ended January 31, 2024, the Company incurred $55,505 in costs related to revenue generation, primarily stemming from services provided by another related party, HF Int’l Education, a subsidiary of SH Oversea.

 

Office space at Rosemead, CA is provided to Hartford Great Health Corp. at no cost by the sole executive officer. No provision for these costs has been included in these financial statements as the amounts are not material.

 

NOTE 5. COMMITMENTS AND CONTINGENCIES

 

There has been no material contractual obligations and commitments as of January 31, 2024.

 

NOTE 6. SEGMENT INFORMATION

 

Accounting Standards Codification (“ASC”) 280, “Segment Reporting,” requires public companies to report financial and descriptive information about their reportable operating segments. We identify our operating segments based on how our chief operating decision maker internally evaluates separate financial information, business activities and management responsibility.

 

The Company used to operate in two reportable segments: hospitality (hotel and travel agency) and early childhood education industry in China in the past years. Due to the disposal of operating subsidiaries on August 1, 2022, we currently have one reportable segment for advertising services.

 

NOTE 7. SUBSEQUENT EVENTS

 

In accordance with ASC 855, “Subsequent Events”, the Company has evaluated subsequent events through the date of issuance of these unaudited financial statements and subsequent events were noted.

 

On February 23, 2024, the Company borrowed $85,000 from its major stockholder, Mr. Lianyue Song., in the form of a demand note at 5% per annum.

 

On March 1, 2024, the Company returned $70,000, a portion of the notes payable to the related party, Hartford Hotel Investment Inc.

 

In the month of February 2024, HFZY has entered advertising service contracts with ten customers and received approximately RMB 8.11 million (about USD1.13 million) as advanced payment from these customers. HFZY also entered a major supplier contract for advertising placement and prepaid RMB 7.70 million (about USD1.07 million) to the supplier.

 

11

 

 

Forward-Looking Statements

 

This Form 10-Q contains or incorporates by reference “forward-looking statements,” as that term is used in federal securities laws, about our financial condition, results of operations and business. These statements include, among others:

 

- statements concerning the benefits that we expect will result from our business activities and results of business development that we contemplate or have completed, such as increased revenues; and statements of our expectations, beliefs, future plans and strategies, anticipated developments and other matters that are not historical facts. These statements may be made expressly in this document or may be incorporated by reference to other documents that we will file with the SEC. You can find many of these statements by looking for words such as “believes,” “expects,” “anticipates,” “estimates” or similar expressions used in this report or incorporated by reference in this report.

 

These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause our actual results to be materially different from any future results expressed or implied in those statements. Because the statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied. We caution you not to put undue reliance on these statements, which speak only as of the date of this report. Further, the information contained in this document or incorporated herein by reference is a statement of our present intention and is based on present facts and assumptions, and may change at any time and without notice, based on changes in such facts or assumptions.

 

Item 2. Management’s Discussion and Analysis or Plan of Operation Overview

 

This discussion updates our business plan for the six-month periods ending January 31, 2024. It also analyzes our financial condition at January 31, 2024 and compares it to our financial condition at July 31, 2023. This discussion and analysis should be read in conjunction with our audited financial statements for the year ended July 31, 2023, including footnotes, contained in our Annual Report on Form 10-K, and with the unaudited financial statements for the interim period ended January 31, 2024, including footnotes, which are included in this quarterly report.

 

Overview of the Business

 

Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008, under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018, and since then we have been engaged in activities to formulate and implement our business plan as set forth below.

 

Ability to continue as a “going concern”.

 

The independent registered public accounting firms’ reports on our financial statements as of July 31, 2023, includes a “going concern” explanatory paragraph that describes substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to the factors prompting the explanatory paragraph are discussed in the financial statements, including footnotes thereto.

 

Plan of Operation

 

As of January 31, 2024, the company has issued a total of 100,108,000 shares of common stock. On December 11, 2018, 96,090,000 shares of common stock were issued at the price of $0.02 per share to raise an additional $1,921,800 in capital. On November 24, 2020, the Company issued additional 1,000,000 shares of common stock to a significant shareholder of the Company at $0.02 per share.

 

On December 28, 2018, the Company acquired Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF”). On March 22, 2019, the Company acquired 60 percent of Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”). On March 20, 2019, the Company acquired Shanghai Hartford Comprehensive Health Management, Ltd. (“HFSH”). Since 2019, HFSH had acquired and formed multiple subsidiaries and tried to develop the childhood education and childcare business. Impacted by Covid-19 pandemic and the government regulation implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, to avoid further operation losses, on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell HZHF and its subsidiaries for $1,000 (RMB 6,500).

 

The company’s sole subsidiary, HFSH was working with herbal manufacturers to develop new herbal health supplement products for wholesale distribution in China. Due to deflation in China, demand of herbal health supplement was lower than expected. Therefore, HFSH decided to deviate from its prior business focus and to engage in social media advertising endeavors. On January 10, 2024, HFSH changed its legal name from Shanghai Hartford Health Management, Ltd. to Hartford ZY Culture Media (Shanghai) Co., Ltd., hereon refer to as “HFZY”. and started to deliver media and advertisement services. The pent-up demand from social media influencers’ marketing needs on social media apps lead HFZY to seize the opportunity in providing advertisement services. HFZY begins to engage in social media advertising business on mainstream social media platforms such as Tik Tok, Toutiao, Kwai, RED, WeChat, and more. As an advertising partner of China’s major social media platforms, it provides customers with vertical integration services from early-stage advertising video creativity, photograph shooting, editing, to advertising operation and management on social media apps. HFZY is one of the total solution advertising providers for domestic social media industry in China.

 

Based on the current social media advertising business, HFZY will gradually launch overseas TikTok advertising campaign in 2024, providing social media advertising solutions for domestic Chinese customers to engage in international markets in the United States.

 

Subsequently in the month of February 2024, HFZY has entered advertising service contracts with ten customers and received approximately RMB 8.11 million (USD1.13 million) as advanced payment from these customers. HFZY also entered a major supplier contract for advertising placement and prepaid RMB 7.70 million (USD1.07 million). The Company expects the number of customers to grow and the advertising service revenue will significantly increase in the next few months due to the vast demand in social media advertising services.

 

12

 

 

Results of Operations – Three months ended January 31, 2024 Compared to Three months ended January 31, 2023.

 

Revenue: We recognized $62,443 and $nil revenue in the three months ended January 31, 2024 and 2023, respectively. For the three months ended January 31, 2024, the revenue was primarily generated from designing, making and placing video advertising for Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives. As both early childhood education services and hospitality services have been sold on August 1 2022, there was no revenue recognized for the three months ended January 31, 2023.

 

Operating Cost and Expenses: Cost of revenue increased to $55,505 for the three months ended January 31, 2024, compared to $nil during the comparable period of 2023. The increase of Cost of revenue was mainly due to the increase of the revenue. During the three months ended January 31, 2024, the selling, general and administrative expenses slightly increased to $21,942 compared to $21,362 during the comparable period of 2023.

 

Other Income (Expense): Other expense, net amount of $4,993 for the three months ended January 31, 2024, compared to $4,089 for the three months ended January 31, 2023. Other expenses for both periods were mainly resulted from interest expenses.

 

Net Income (Loss): We recorded a net loss of $19,997 or $(0.00) per share for the three months ended January 31, 2024, compared to a net loss of $25,451 or $(0.00) for the three months ended January 31, 2023, due to the factors discussed above.

 

Results of Operations – Six months ended January 31, 2024 Compared to Six months ended January 31, 2023.

 

Revenue: We recognized $62,443 and $nil revenue in the six months ended January 31, 2024 and 2023, respectively. For the six months ended January 31, 2024, the revenue was primarily generated from designing, making and placing video advertising for Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives. As both early childhood education services and hospitality services have been sold on August 1 2022, there was no revenue recognized for the six months ended January 31, 2023.

 

Operating Cost and Expenses: Cost of revenue increased to $55,505 for the six months ended January 31, 2024, compared to $nil during the comparable period of 2023. The increase of Cost of revenue was mainly due to the increase of the revenue. During the six months ended January 31, 2024, the selling, general and administrative expenses decreased to $42,134 compared to $76,010 during the comparable period of 2023. The decrease was due to the reduction of professional expenses occurred in US as a result of the downsize of business operation.

 

Other Income (Expense): Other expense, net amount of $10,257 for the six months ended January 31, 2024, compared to Other income, net amount of $530,961 for the corresponding period of 2023. Other expense for the six months ended January 31, 2024 was mainly resulted from interest expenses. Other income for the six months ended January 31, 2023, was mainly resulted from the gain on disposal of subsidiaries offset by interest expenses.

 

Net Income (Loss): We recorded a net loss of $45,453 or $(0.00) per share for the six months ended January 31, 2024, compared to a net income of $454,951 or $0.00 per share for the six months ended January 31, 2023, due to the factors discussed above.

 

Liquidity and Capital Resources

 

As of January 31, 2024, we had a working capital deficit of $4,562,442 comprised of current assets of $9,730 and current liabilities of $4,572,172. This represents a increase of $72,006 in the working capital deficit from the July 31, 2023 amount of $4,490,436.

 

We believe that our funding requirements for the next twelve months will be in excess of $800,000. We are currently seeking for further funding through related parties’ loan and finance.

 

As of January 31, 2024, the company has issued a total of 100,108,000 shares of common stock. On December 11, 2018, 96,090,000 shares of common stock were issued at the price of $0.02 per share to raise an additional $1,921,800 in capital. On November 24, 2020, the Company issued additional 1,000,000 shares of common stock to a significant shareholder of the Company at $0.02 per share.

 

We will seek additional financing in the form of debt or equity. There is no assurance that we will be able to obtain any needed financing on favorable terms, or at all, or that we will find qualified purchasers for the sale of our stock. Any sales of our securities would dilute the ownership of our existing investors.

 

13

 

 

Cash Flows – Six months ended January 31, 2024 Compared to Six months ended January 31, 2023

 

Operating Activities

 

Cash used in operating activities was $34,293 for the six months ended January 31, 2024 as compared to $63,128 cash used in the operations for the six months ended January 31, 2023. During the six months ended January 31, 2024, we recorded net loss of $45,453 offset by a $10,330 increase of related party payables.

 

During the six months ended January 31, 2023, we recorded net income of $454,951, adjusted by subsidiary disposal gain of $539,230, related party payables net with receivables increased by $26,955 and offset by other current payable decreased by $6,631.

 

Investing activities

 

Nil of investing activities occurred during the six months ended January 31, 2024 and 2023, respectively.

 

Financing activities

 

Cash provided by financing activities was $36,971 for the six months ended January 31, 2024 as compared to $60,000 cash provided by financing activities for six months ended January 31, 2023. The cash flows provided by financing activities for both of the six months ended January 31, 2024 and 2023, were primarily from the proceeds of notes payable. The notes payable was borrowed from one related party with 5% annual interest rate. See Note 4 Related Party Transactions.

 

Future Capital Expenditures

 

We are currently engaging a consulting firm to evaluate and facilitate the potential uplisting of the Company’s stock from the OTC market to the Nasdaq exchange. If all conditions align favorably, the Company intends to secure financing through either debt or equity. The funds raised will be allocated to cover the expenses associated with the uplisting process.

 

14

 

 

Off-Balance Sheet Arrangements

 

As of and subsequent to January 31, 2024, we have no off-balance sheet arrangements.

 

Contractual Commitments

 

As of January 31, 2024, we don’t have material contractual commitments.

 

Critical Accounting Policies

 

There have been no other changes in our critical accounting policies since our most recent audit dated July 31, 2023.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

An evaluation was performed under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer (principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that, as of January 31, 2024, our disclosure controls and procedures were not effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms due to material weaknesses in our internal controls described below.

 

Management’s Report on Internal Control over Financial Reporting

 

Management’s assessment identified several material weaknesses in our internal control over financial reporting. These material weaknesses include the following:

 

  ● Lack of proper authorization and approval procedures on significant business transactions.
     
  ● Lack of competence accounting personnel at entity level and proper segregation of duties implemented.

 

Changes in Internal Control

 

During the six months ended January 31, 2024, there has been no change in internal control within the Company.

 

15

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

We were not subject to any other legal proceedings during the six months ended January 31, 2024, and are not currently subject to any legal proceedings, and to the best of our knowledge, no such proceeding is threatened, the results of which would have a material impact on our results of operation or financial condition. Nor, to the best of our knowledge, are any of our officers or directors involved in any legal proceedings in which we are an adverse party.

 

Item 1A. Risk Factors.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None

 

Item 3. Defaults Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures

 

Not applicable to our Company.

 

Item 5. Other Information

 

Not applicable to our Company.

 

Item 6. Exhibits.

 

The following exhibits are filed with or incorporated by referenced in this report:

 

31.1* Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Rose Hong Wang.

 

31.2* Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Sheng-Yih Chang

 

32.1* Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Rose Hong Wang and Sheng-Yih Chang

 

101 Interactive Data Files

 

101.INS Inline XBRL Instance Document

 

101.SCH Inline XBRL Taxonomy Extension Schema Document

 

101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document

 

101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

 

101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

16

 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  HARTFORD GREAT HEALTH CORP.
     
Date: March 14, 2024 By: /s/ ROSE HONG WANG
    Rose Hong Wang
    Chief Executive Officer

 

17
 EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934

 

I, Rose Hong Wang, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Hartford Great Health Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 14, 2024

 

  /s/ ROSE HONG WANG
  Rose Hong Wang
  Chief Executive Officer

 

 
 EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934

 

I, Sheng-Yih Chang, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Hartford Great Health Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 14, 2024

 

  /s/ Sheng-Yih Chang
  Sheng-Yih Chang
  Chief Financial Officer

 

 
 EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

Certification of Periodic Financial Report by the Chief Executive Officer and

Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Solely for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and Chief Financial Officer of Hartford Great Health Corp. (the “Company”), hereby certify, based on our knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended January 31, 2024 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 14, 2024 /s/ ROSE HONG WANG
  Rose Hong Wang
  Chief Executive Officer
   
Date: March 14, 2024 /s/ SHENG-YIH CHANG
  Sheng-Yih Chang
  Chief Financial Officer

 

 

 

 EX-101.SCH 5 hfus-20240131.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - ACQUISITIONS AND DISPOSALS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - ACQUISITIONS AND DISPOSALS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - ACQUISITIONS AND DISPOSALS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 hfus-20240131_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 hfus-20240131_def.xml XBRL DEFINITION FILE EX-101.LAB 8 hfus-20240131_lab.xml XBRL LABEL FILE Related Party, Type [Axis] Related Party [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Noncontrolling Interest [Member] Business Acquisition [Axis] Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. [Member] Shanghai Qiao Garden International Travel Agency [Member] Investment, Name [Axis] Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd. [Member] Shanghai HDFD Zhongli Education Technology Co Ltd [Member] Ownership [Axis] Two Individual Investors [Member] Disposal Group Name [Axis] Shanghai Oversea [Member] Disposal Group Classification [Axis] Discontinued Operations, Disposed of by Sale [Member] Hartford International Education Technology Co., Ltd [Member] Legal Entity [Axis] Hangzhou Hartford Comprehensive Health Management Ltd [Member] Related Party Transaction [Axis] Shanghai Dubian Assets Management Ltd [Member] Shanghai Luo Sheng International Trade Ltd. [Member] SHQiahong [Member] Shanghai Oversea Chinese Culture Media Ltd [Member] Hartford Hotel Investment Inc [Member] Subsequent Event Type [Axis] Subsequent Event [Member] MR Lianyu Song [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current Assets Cash and cash equivalents Prepaid and Other current receivables Related party receivable Total Current Assets Non-current Assets Property and equipment, net Total Non-current Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities Related party loan and payables Other current payable Total Current Liabilities TOTAL LIABILITIES Commitments and contingencies Stockholders’ Equity (Deficit) Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding Common stock - $0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of January 31, 2024 and July 31, 2023. Additional paid-in capital Accumulated deficit Accumulated other comprehensive income Total Stockholders’ Deficit TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT Statement of Financial Position [Abstract] Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares outstanding Income Statement [Abstract] Revenue - Related Party Cost of revenue - Related Party Gross Profit Operating expenses Selling, general and administrative Total operating expenses Operating Loss Other Income (Expense) Interest (expense), net Gain on disposal of subsidiary Other income (expense), net Other income (expense), net (Loss) income before income taxes Income Tax Expense Net (loss) income Net (loss) income per common share: Net loss per common share, basic Net loss per common share, diluted Weighted average shares outstanding - basic Weighted average shares outstanding - diluted Net (loss) income Other Comprehensive (loss) income, net of income tax Foreign currency translation adjustments Total other comprehensive (loss) income Total Comprehensive (loss) income Statement [Table] Statement [Line Items] Beginning balance, value Balance, shares Net income (loss) Foreign currency translation adjustment Disposal of subsidiary Balance, Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income (loss) to net cash used in operating activities: Depreciation Disposal of subsidiaries Changes in operating assets and liabilities: Prepaid and Other current receivables Related party receivables and payables Other current payable Net cash used in operating activities Cash flows from investing activities: Net cash used in investing activities Cash flows from financing activities: Proceeds of related party notes payable Advances from related parties Net cash provided by financing activities Effect of exchange rate changes on cash Net change in Cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Supplemental Cash Flow Information Interest paid Income taxes paid Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] GOING CONCERN Business Combination and Asset Acquisition [Abstract] ACQUISITIONS AND DISPOSALS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Segment Reporting [Abstract] SEGMENT INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Organization Basis of Presentation Use of Estimates Income Taxes Revenue Recognition Recent Accounting Pronouncements SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY Business acquisition, percentage of voting interests acquired Equity ownership percentage Equity ownership percentage Percentage of voting interests sold Sale of business unit, consideration Income tax examination description Revenues Accumulated deficit Multiemployer Plan [Table] Multiemployer Plan [Line Items] Cash and cash equivalents Prepaid and Other current receivables Related party receivable Inventory Property and equipment - Net ROU assets-Operating lease Other assets Related party loan and payables Contract liabilities Lease liabilities, current and noncurrent Other current payable Other liabilities Noncontrolling interest Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest Consideration Gain on disposal of the subsidiary Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Business acquired ownership interest Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Receivables Accounts payable, related parties Debt instrument, interest rate, stated percentage Interest expense, related party Unpaid principal Cost of revenue Subsequent Event [Table] Subsequent Event [Line Items] Proceeds from related party debt Debt instrument interest rate effective percentage Payment of related party notes payable Advanced payment from contracted customers Prepaid advertising Proceeds from advance from related parties. Organization [Policy Text Block] Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd [Member] Shanghai Qiao Garden International Travel Agency [Member] Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd. [Member] Shanghai Hdfd Zhongli Education Technology Co Ltd [Member] Two Individual Investors [Member] Shanghai Oversea [Member] Hartford International Education Technology Co., Ltd [Member] Hangzhou Hartford Comprehensive Health Management Ltd [Member] Shanghai Luo Sheng International Trade Ltd. [Member] Disposal group, including discontinued operation, related party receivable. Disposal group including discontinued operation right of use assets operating lease. Disposal group including discontinued operation related party loan and payable. Disposal group including discontinued operation contract liiabilities current. Disposal group including discontinued operation lease liabilities. Disposal group, including discontinued operation, noncontrolling interest. Disposal group, including discontinued operation, net assets of the subsidiary. SHQiahong [Member] Shanghai Oversea Chinese Culture Media Ltd [Member] Hartford Hotel Investment Inc [Member] MR Lianyu Song [Member] Shanghai Dubian Assets Management Ltd [Member] Disposal group including discontinued operation percentage of voting interests sold. Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Other Comprehensive Income (Loss), Net of Tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Broker-Dealer Related Receivables (Payables), Net Increase (Decrease) in Other Accounts Payable Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Subsidiary, Ownership Percentage, Parent Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Disposal group, including discontinued operation, related party receivable DisposalGroupIncludingDiscontinuedOperationRelatedPartyLoanAndPayable Disposal Group, Including Discontinued Operation, Other Liabilities, Current Disposal Group, Including Discontinued Operation, Other Liabilities EX-101.PRE 9 hfus-20240131_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover - shares
 6 Months Ended
Jan. 31, 2024
Mar. 14, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jan. 31, 2024  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --07-31  
Entity File Number 000-54439  
Entity Registrant Name HARTFORD GREAT HEALTH CORP.  
Entity Central Index Key 0001482554  
Entity Tax Identification Number 51-0675116  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 8832 Glendon Way  
Entity Address, City or Town Rosemead  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 91770  
City Area Code (626)  
Local Phone Number 321-1915  
Title of 12(b) Security Common stock, par value $0.001 par value  
Trading Symbol HFUS  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   100,108,000
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Balance Sheets - USD ($)
Jan. 31, 2024
Jul. 31, 2023
Current Assets    
Cash and cash equivalents $ 8,484 $ 5,793
Prepaid and Other current receivables 282 280
Total Current Assets 9,730 7,037
Non-current Assets    
Property and equipment, net 597 730
Total Non-current Assets 597 730
TOTAL ASSETS 10,327 7,767
Current Liabilities    
Other current payable 131,835 130,279
Total Current Liabilities 4,572,172 4,497,473
TOTAL LIABILITIES 4,572,172 4,497,473
Commitments and contingencies
Stockholders’ Equity (Deficit)    
Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding
Common stock - $0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of January 31, 2024 and July 31, 2023. 100,108 100,108
Additional paid-in capital 2,173,521 2,173,521
Accumulated deficit (7,049,170) (7,003,717)
Accumulated other comprehensive income 213,696 240,382
Total Stockholders’ Deficit (4,561,845) (4,489,706)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 10,327 7,767
Related Party [Member]    
Current Assets    
Related party receivable 964 964
Current Liabilities    
Related party loan and payables $ 4,440,337 $ 4,367,194
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jan. 31, 2024
Jul. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares outstanding 100,108,000 100,108,000
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2024
Jan. 31, 2023
Income Statement [Abstract]        
Revenue - Related Party $ 62,443 $ 62,443
Cost of revenue - Related Party 55,505 55,505
Gross Profit 6,938 6,938
Operating expenses        
Selling, general and administrative 21,942 21,362 42,134 76,010
Total operating expenses 21,942 21,362 42,134 76,010
Operating Loss (15,004) (21,362) (35,196) (76,010)
Other Income (Expense)        
Interest (expense), net (5,067) (4,089) (10,331) (8,178)
Gain on disposal of subsidiary 539,230
Other income (expense), net 74 74 (91)
Other income (expense), net (4,993) (4,089) (10,257) 530,961
(Loss) income before income taxes (19,997) (25,451) (45,453) 454,951
Income Tax Expense
Net (loss) income $ (19,997) $ (25,451) $ (45,453) $ 454,951
Net (loss) income per common share:        
Net loss per common share, basic $ (0.00) $ (0.00) $ (0.00) $ 0.00
Net loss per common share, diluted $ (0.00) $ (0.00) $ (0.00) $ 0.00
Weighted average shares outstanding - basic 100,108,000 100,108,000 100,108,000 100,108,000
Weighted average shares outstanding - diluted 100,108,000 100,108,000 100,108,000 100,108,000
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2024
Jan. 31, 2023
Income Statement [Abstract]        
Net (loss) income $ (19,997) $ (25,451) $ (45,453) $ 454,951
Other Comprehensive (loss) income, net of income tax        
Foreign currency translation adjustments (123,853) (322,644) (26,686) 23,289
Total other comprehensive (loss) income (123,853) (322,644) (26,686) 23,289
Total Comprehensive (loss) income $ (143,850) $ (348,095) $ (72,139) $ 478,240
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Jul. 31, 2022 $ 100,108 $ 2,173,521 $ (7,400,620) $ (16,742) $ (1,288,916) $ (6,432,649)
Balance, shares at Jul. 31, 2022 100,108,000          
Net income (loss) 480,402     480,402
Foreign currency translation adjustment       345,933 (18,670) 327,263
Disposal of subsidiary         1,307,586 1,307,586
Balance, at Oct. 31, 2022 $ 100,108 2,173,521 (6,920,218) 329,191 (4,317,398)
Balance, shares at Oct. 31, 2022 100,108,000          
Beginning balance, value at Jul. 31, 2022 $ 100,108 2,173,521 (7,400,620) (16,742) (1,288,916) (6,432,649)
Balance, shares at Jul. 31, 2022 100,108,000          
Net income (loss)           454,951
Balance, at Jan. 31, 2023 $ 100,108 2,173,521 (6,945,669) 6,547 (4,665,493)
Balance, shares at Jan. 31, 2023 100,108,000          
Beginning balance, value at Oct. 31, 2022 $ 100,108 2,173,521 (6,920,218) 329,191 (4,317,398)
Balance, shares at Oct. 31, 2022 100,108,000          
Net income (loss) (25,451) (25,451)
Foreign currency translation adjustment (322,644) (322,644)
Balance, at Jan. 31, 2023 $ 100,108 2,173,521 (6,945,669) 6,547 (4,665,493)
Balance, shares at Jan. 31, 2023 100,108,000          
Beginning balance, value at Jul. 31, 2023 $ 100,108 2,173,521 (7,003,717) 240,382 (4,489,706)
Balance, shares at Jul. 31, 2023 100,108,000          
Net income (loss) (25,456) (25,456)
Foreign currency translation adjustment 97,167 97,167
Balance, at Oct. 31, 2023 $ 100,108 2,173,521 (7,029,173) 337,549 (4,417,995)
Balance, shares at Oct. 31, 2023 100,108,000          
Beginning balance, value at Jul. 31, 2023 $ 100,108 2,173,521 (7,003,717) 240,382 (4,489,706)
Balance, shares at Jul. 31, 2023 100,108,000          
Net income (loss)           (45,453)
Balance, at Jan. 31, 2024 $ 100,108 2,173,521 (7,049,170) 213,696 (4,561,845)
Balance, shares at Jan. 31, 2024 100,108,000          
Beginning balance, value at Oct. 31, 2023 $ 100,108 2,173,521 (7,029,173) 337,549 (4,417,995)
Balance, shares at Oct. 31, 2023 100,108,000          
Net income (loss) (19,997) (19,997)
Foreign currency translation adjustment (123,853)   (123,853)
Balance, at Jan. 31, 2024 $ 100,108 $ 2,173,521 $ (7,049,170) $ 213,696 $ (4,561,845)
Balance, shares at Jan. 31, 2024 100,108,000          
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Cash flows from operating activities:    
Net (loss) income $ (45,453) $ 454,951
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation 136
Disposal of subsidiaries (539,230)
Changes in operating assets and liabilities:    
Prepaid and Other current receivables 827
Related party receivables and payables 10,330 26,955
Other current payable 694 (6,631)
Net cash used in operating activities (34,293) (63,128)
Cash flows from investing activities:    
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds of related party notes payable 36,000 60,000
Advances from related parties 971
Net cash provided by financing activities 36,971 60,000
Effect of exchange rate changes on cash 13 (1,524)
Net change in Cash, cash equivalents and restricted cash 2,691 (4,652)
Cash, cash equivalents and restricted cash at beginning of period 5,793 15,227
Cash, cash equivalents and restricted cash at end of period 8,484 10,575
Supplemental Cash Flow Information    
Interest paid
Income taxes paid
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Jan. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. The financial statements and notes are the responsibility of the Company’s management. These accounting policies conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied in the preparation of the financial statements. This disclosure should be read in conjunction with our audited financial statements for the year ended July 31, 2023, including footnotes, contained in our Annual Report on Form 10-K.

 

Organization

 

Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.

 

Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s 60 percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Health Management, Ltd. (“HFSH”) and its 90 percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020.

 

The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two 100% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”). Gelinke temporally ceased its operations by the end of August 2021. On August 31, 2021, PDHJ established one 96% owned subsidiary, Shanghai HDFD Zhongli Education Technology Co., Ltd. (“Zhongli”), two individual investors hold the remaining 4% ownership.

 

Impacted by the government regulation implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, to avoid further operation losses, on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell 90 percent ownership of HF Int’l Education and its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell 100 percent ownership of HZHF and its subsidiaries for $1,000 (RMB 6,500). See Note 3 Acquisitions and Disposals.

 

On January 10, 2024, HFSH changed its legal name from Shanghai Hartford Health Management, Ltd. to Hartford ZY Culture Media (Shanghai) Co., Ltd., hereon refer to as “HFZY”. and started to deliver media and advertisement services. HFZY mainly engage in social media advertising business on mainstream social media platforms such as Tik Tok, Toutiao, Kwai, RED, WeChat, and more. As an advertising partner of China’s major social media platforms, it provides customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. HFZY is one of the total solution advertising providers for domestic social media industry in China.

 

Basis of Presentation

 

The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.

 

Revenue Recognition

 

The Company follows the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms.

 

The Company is developing business plan to provide customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. Most of the advertising revenue will be generated by placing ad products on Tik Tok, Toutiao, Kwai, RED, WeChat, and other third-party affiliated websites and mobile applications. The revenues from the display of impression-based ads will be recognized in the contracted period in which the impressions are delivered. The Company will also generate revenue from the delivery of certain services, such as the creation and delivery of ads that appear on third-party publishers’ websites and social platforms. The Company recognizes revenues from these services in the period in which the service is completed. During current reporting period, the Company generated $62,443 revenue from designing, making, and placing video advertising for our related party customers, primarily Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives.

 

In the past years, the company’s main operations were focusing on Early childhood education services and Hospitality services. Impacted by the Covid-19 pandemic and Chinese regulation on education industry, both early childhood education services and hospitality services have been sold on August 1 2022. Thus, there was no revenue recognized for the three and six months ended January 31, 2023. See Note 3 Acquisitions and Disposals.

 

Recent Accounting Pronouncements.

 

Recently not yet adopted accounting pronouncements

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new guidance requires enhanced disclosures about income tax expenses. The Company is required to adopt this guidance in the first quarter of the fiscal year 2026. Early adoption is permitted on a prospective basis. We are currently evaluating the impact of this ASU on our annual income tax disclosures.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new guidance requires enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for its annual reporting in fiscal year 2025 and for interim period reporting beginning the first quarter of fiscal year 2026 on a retrospective basis. Early adoption is permitted. We are currently evaluating the impact of this ASU on our segment disclosures.

 

The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

 

 
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOING CONCERN
 6 Months Ended
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 2. GOING CONCERN

 

The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, Hartford Great Health Corp. has incurred losses since inception, resulting in an accumulated deficit of $7,049,170 as of January 31, 2024. This condition  raises substantial doubt about the ability of Hartford Great Health Corp. to continue as a going concern.

 

In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to Hartford Great Health Corp., and ultimately achieving profitable operations. Management believes that Hartford Great Health Corp.’s business plan provides it with an opportunity to continue as a going concern. However, management cannot provide assurance that Hartford Great Health Corp. will meet its objectives and be able to continue in operation.

 

The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of Hartford Great Health Corp. to continue as a going concern.

 
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACQUISITIONS AND DISPOSALS
 6 Months Ended
Jan. 31, 2024
Business Combination and Asset Acquisition [Abstract]  
ACQUISITIONS AND DISPOSALS

NOTE 3. ACQUISITIONS AND DISPOSALS

 

In January 2019, HFSH entered agreements to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). On August 1, 2022, HFSH decided to withdraw from the agreement entered in January 2019 to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). There was no penalty levied or to be levied due to delayed execution or inexecution.

 

Impacted by the government regulation newly implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, the Company’s business hasn’t been developed as planned and occurred significant loss from the early child education practice. To avoid further operation losses, subsequently on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell 90 percent ownership of HF Int’l Education and its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell 100 percent ownership of HZHF and its subsidiaries for $1,000 (RMB 6,500).

SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY

Net assets (liabilities) disposed of:    
     
Cash and cash equivalents  $4,938 
Prepaid and Other current receivables   45,532 
Related party receivable   428,519 
Inventory   305,124 
Property and equipment - Net   582,707 
ROU assets-Operating lease   2,836,698 
Other assets   296,218 
Related party loan and payables   (1,321,549)
Contract liabilities   (547,906)
Lease liabilities, current and noncurrent   (3,715,688)
Other current payable   (401,782)
Other liabilities   (357,796)
Noncontrolling interest   1,307,586 
Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest   (537,399)
Consideration   1,831 
Gain on disposal of the subsidiaries  $(539,230)

 

 
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTY TRANSACTIONS
 6 Months Ended
Jan. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 4. RELATED PARTY TRANSACTIONS

 

Related Party Receivables

 

HFUS had $964 related party receivable as of both January 31, 2024 and July 31, 2023, due from SH Oversea in relation to the disposal consideration.

 

Related Party Payables and loans

 

As of January 31, 2024 and July 31, 2023, amounts of $582,601 and $586,236, respectively, are payable to SH Qiaohong. The balances were mainly funding support from SH Qiaohong for operation. The funding support bears no interest and due on demand.

 

HFSH had payable balances to Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), an entity previously was managed by the same management team, in the amounts of $3,321,300 and $3,291,324 as of January 31, 2024 and July 31, 2023, respectively. The payable is funding support from SH Oversea for operation, bears no interest and due on demand.

 

HFUS borrowed in form of a short-term loan at 5% per annum from a related party, Hartford Hotel Investment Inc., an entity managed by the same management team. $5,067 and $10,331 of interest expenses were recorded during the three and six months ended January 31, 2024, respectively. $4,089 and $8,178 of interest expenses were recorded during the three and six months ended January 31, 2023, respectively. As of January 31, 2024 and July 31, 2023, the unpaid principal and interest amount of $463,831 and $417,501, respectively, will be due on demand.

 

The remaining related party payable of $72,605 and $72,133 as of January 31, 2024 and July 31, 2023, respectively, represents the unpaid portion of operating advances made to the Company by its main shareholder, Mr. Lianyue Song. These advances do not bear interest and are considered due on demand.

 

Other Related Party Transactions

 

During the three and six months ended January 31, 2024, the Company generated $62,443 revenue from designing, making, and placing video advertising for its related parties, primarily Shanghai DuBian Assets Management Ltd., which is managed by the Company’s major shareholder’s relatives. For the three and six months ended January 31, 2024, the Company incurred $55,505 in costs related to revenue generation, primarily stemming from services provided by another related party, HF Int’l Education, a subsidiary of SH Oversea.

 

Office space at Rosemead, CA is provided to Hartford Great Health Corp. at no cost by the sole executive officer. No provision for these costs has been included in these financial statements as the amounts are not material.

 
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES
 6 Months Ended
Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 5. COMMITMENTS AND CONTINGENCIES

 

There has been no material contractual obligations and commitments as of January 31, 2024.

 
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION
 6 Months Ended
Jan. 31, 2024
Segment Reporting [Abstract]  
SEGMENT INFORMATION

NOTE 6. SEGMENT INFORMATION

 

Accounting Standards Codification (“ASC”) 280, “Segment Reporting,” requires public companies to report financial and descriptive information about their reportable operating segments. We identify our operating segments based on how our chief operating decision maker internally evaluates separate financial information, business activities and management responsibility.

 

The Company used to operate in two reportable segments: hospitality (hotel and travel agency) and early childhood education industry in China in the past years. Due to the disposal of operating subsidiaries on August 1, 2022, we currently have one reportable segment for advertising services.

 
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUBSEQUENT EVENTS
 6 Months Ended
Jan. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 7. SUBSEQUENT EVENTS

 

In accordance with ASC 855, “Subsequent Events”, the Company has evaluated subsequent events through the date of issuance of these unaudited financial statements and subsequent events were noted.

 

On February 23, 2024, the Company borrowed $85,000 from its major stockholder, Mr. Lianyue Song., in the form of a demand note at 5% per annum.

 

On March 1, 2024, the Company returned $70,000, a portion of the notes payable to the related party, Hartford Hotel Investment Inc.

 

In the month of February 2024, HFZY has entered advertising service contracts with ten customers and received approximately RMB 8.11 million (about USD1.13 million) as advanced payment from these customers. HFZY also entered a major supplier contract for advertising placement and prepaid RMB 7.70 million (about USD1.07 million) to the supplier.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 6 Months Ended
Jan. 31, 2024
Accounting Policies [Abstract]  
Organization

Organization

 

Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.

 

Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s 60 percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Health Management, Ltd. (“HFSH”) and its 90 percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020.

 

The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two 100% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”). Gelinke temporally ceased its operations by the end of August 2021. On August 31, 2021, PDHJ established one 96% owned subsidiary, Shanghai HDFD Zhongli Education Technology Co., Ltd. (“Zhongli”), two individual investors hold the remaining 4% ownership.

 

Impacted by the government regulation implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, to avoid further operation losses, on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell 90 percent ownership of HF Int’l Education and its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell 100 percent ownership of HZHF and its subsidiaries for $1,000 (RMB 6,500). See Note 3 Acquisitions and Disposals.

 

On January 10, 2024, HFSH changed its legal name from Shanghai Hartford Health Management, Ltd. to Hartford ZY Culture Media (Shanghai) Co., Ltd., hereon refer to as “HFZY”. and started to deliver media and advertisement services. HFZY mainly engage in social media advertising business on mainstream social media platforms such as Tik Tok, Toutiao, Kwai, RED, WeChat, and more. As an advertising partner of China’s major social media platforms, it provides customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. HFZY is one of the total solution advertising providers for domestic social media industry in China.

 
Basis of Presentation

Basis of Presentation

 

The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation.

 
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

 
Income Taxes

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.

 
Revenue Recognition

Revenue Recognition

 

The Company follows the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms.

 

The Company is developing business plan to provide customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. Most of the advertising revenue will be generated by placing ad products on Tik Tok, Toutiao, Kwai, RED, WeChat, and other third-party affiliated websites and mobile applications. The revenues from the display of impression-based ads will be recognized in the contracted period in which the impressions are delivered. The Company will also generate revenue from the delivery of certain services, such as the creation and delivery of ads that appear on third-party publishers’ websites and social platforms. The Company recognizes revenues from these services in the period in which the service is completed. During current reporting period, the Company generated $62,443 revenue from designing, making, and placing video advertising for our related party customers, primarily Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives.

 

In the past years, the company’s main operations were focusing on Early childhood education services and Hospitality services. Impacted by the Covid-19 pandemic and Chinese regulation on education industry, both early childhood education services and hospitality services have been sold on August 1 2022. Thus, there was no revenue recognized for the three and six months ended January 31, 2023. See Note 3 Acquisitions and Disposals.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements.

 

Recently not yet adopted accounting pronouncements

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new guidance requires enhanced disclosures about income tax expenses. The Company is required to adopt this guidance in the first quarter of the fiscal year 2026. Early adoption is permitted on a prospective basis. We are currently evaluating the impact of this ASU on our annual income tax disclosures.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new guidance requires enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for its annual reporting in fiscal year 2025 and for interim period reporting beginning the first quarter of fiscal year 2026 on a retrospective basis. Early adoption is permitted. We are currently evaluating the impact of this ASU on our segment disclosures.

 

The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACQUISITIONS AND DISPOSALS (Tables)
 6 Months Ended
Jan. 31, 2024
Business Combination and Asset Acquisition [Abstract]  
SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY

SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY

Net assets (liabilities) disposed of:    
     
Cash and cash equivalents  $4,938 
Prepaid and Other current receivables   45,532 
Related party receivable   428,519 
Inventory   305,124 
Property and equipment - Net   582,707 
ROU assets-Operating lease   2,836,698 
Other assets   296,218 
Related party loan and payables   (1,321,549)
Contract liabilities   (547,906)
Lease liabilities, current and noncurrent   (3,715,688)
Other current payable   (401,782)
Other liabilities   (357,796)
Noncontrolling interest   1,307,586 
Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest   (537,399)
Consideration   1,831 
Gain on disposal of the subsidiaries  $(539,230)
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
 3 Months Ended 6 Months Ended
Jan. 31, 2024
USD ($)
Jan. 31, 2023
USD ($)
Jan. 31, 2024
USD ($)
Jan. 31, 2023
USD ($)
Aug. 01, 2022
USD ($)
Aug. 01, 2022
CNY (¥)
Aug. 31, 2021
Dec. 31, 2020
Mar. 23, 2020
Jul. 24, 2019
Income tax examination description     The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government              
Revenues $ 62,443 $ 62,443            
Shanghai Dubian Assets Management Ltd [Member]                    
Revenues     $ 62,443              
Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member]                    
Sale of business unit, consideration         $ 1,831          
Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member] | Hartford International Education Technology Co., Ltd [Member]                    
Sale of business unit, consideration         900 ¥ 5,850        
Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member] | Hangzhou Hartford Comprehensive Health Management Ltd [Member]                    
Sale of business unit, consideration         $ 1,000 ¥ 6,500        
Two Individual Investors [Member]                    
Equity ownership percentage             4.00%      
Hartford International Education Technology Co., Ltd [Member] | Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member]                    
Percentage of voting interests sold         90.00% 90.00%        
Hangzhou Hartford Comprehensive Health Management Ltd [Member] | Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member]                    
Percentage of voting interests sold         100.00% 100.00%        
Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd. [Member]                    
Equity ownership percentage                 100.00% 100.00%
Shanghai HDFD Zhongli Education Technology Co Ltd [Member]                    
Equity ownership percentage             96.00%      
Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. [Member]                    
Business acquisition, percentage of voting interests acquired               60.00%    
Shanghai Qiao Garden International Travel Agency [Member]                    
Business acquisition, percentage of voting interests acquired               90.00%    
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOING CONCERN (Details Narrative) - USD ($)
Jan. 31, 2024
Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 7,049,170 $ 7,003,717
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details) - Shanghai Oversea [Member] - Discontinued Operations, Disposed of by Sale [Member]
Aug. 01, 2022
USD ($)
Multiemployer Plan [Line Items]  
Cash and cash equivalents $ 4,938
Prepaid and Other current receivables 45,532
Related party receivable 428,519
Inventory 305,124
Property and equipment - Net 582,707
ROU assets-Operating lease 2,836,698
Other assets 296,218
Related party loan and payables (1,321,549)
Contract liabilities (547,906)
Lease liabilities, current and noncurrent (3,715,688)
Other current payable (401,782)
Other liabilities (357,796)
Noncontrolling interest 1,307,586
Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest (537,399)
Consideration 1,831
Gain on disposal of the subsidiary $ (539,230)
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACQUISITIONS AND DISPOSALS (Details Narrative)
Aug. 01, 2022
USD ($)
Aug. 01, 2022
CNY (¥)
Jan. 31, 2019
Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member]      
Business Acquisition [Line Items]      
Sale of business unit, consideration $ 1,831    
Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member] | Hartford International Education Technology Co., Ltd [Member]      
Business Acquisition [Line Items]      
Sale of business unit, consideration 900 ¥ 5,850  
Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member] | Hangzhou Hartford Comprehensive Health Management Ltd [Member]      
Business Acquisition [Line Items]      
Sale of business unit, consideration $ 1,000 ¥ 6,500  
Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member] | Hartford International Education Technology Co., Ltd [Member]      
Business Acquisition [Line Items]      
Percentage of voting interests sold 90.00% 90.00%  
Shanghai Oversea [Member] | Discontinued Operations, Disposed of by Sale [Member] | Hangzhou Hartford Comprehensive Health Management Ltd [Member]      
Business Acquisition [Line Items]      
Percentage of voting interests sold 100.00% 100.00%  
Shanghai Luo Sheng International Trade Ltd. [Member]      
Business Acquisition [Line Items]      
Business acquired ownership interest 100.00% 100.00% 100.00%
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2024
Jan. 31, 2023
Jul. 31, 2023
Related Party Transaction [Line Items]          
Accounts payable, related parties $ 72,605   $ 72,605   $ 72,133
Interest expense, related party 5,067 $ 4,089 10,331 $ 8,178  
Unpaid principal 463,831   463,831   417,501
Revenues 62,443 62,443  
Cost of revenue 55,505 55,505  
Related Party [Member]          
Related Party Transaction [Line Items]          
Receivables 964   964   964
SHQiahong [Member]          
Related Party Transaction [Line Items]          
Accounts payable, related parties 582,601   582,601   586,236
Shanghai Oversea Chinese Culture Media Ltd [Member]          
Related Party Transaction [Line Items]          
Accounts payable, related parties $ 3,321,300   $ 3,321,300   $ 3,291,324
Hartford Hotel Investment Inc [Member]          
Related Party Transaction [Line Items]          
Debt instrument, interest rate, stated percentage 5.00%   5.00%    
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUBSEQUENT EVENTS (Details Narrative)
¥ in Thousands
 1 Months Ended 6 Months Ended
Mar. 01, 2024
USD ($)
Feb. 23, 2024
USD ($)
Feb. 29, 2024
USD ($)
Feb. 29, 2024
CNY (¥)
Jan. 31, 2024
USD ($)
Jan. 31, 2023
USD ($)
Feb. 29, 2024
CNY (¥)
Subsequent Event [Line Items]              
Proceeds from related party debt         $ 36,000 $ 60,000  
Subsequent Event [Member]              
Subsequent Event [Line Items]              
Advanced payment from contracted customers     $ 1,130,000 ¥ 8,110      
Prepaid advertising     $ 1,070,000.00       ¥ 7,700
Subsequent Event [Member] | MR Lianyu Song [Member]              
Subsequent Event [Line Items]              
Proceeds from related party debt   $ 85,000          
Debt instrument interest rate effective percentage   5.00%          
Subsequent Event [Member] | Hartford Hotel Investment Inc [Member]              
Subsequent Event [Line Items]              
Payment of related party notes payable $ 70,000            
EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 34 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 37 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 90 137 1 false 25 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://hartfordhealthcare.org/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://hartfordhealthcare.org/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://hartfordhealthcare.org/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://hartfordhealthcare.org/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) Sheet http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) Statements 6 false false R7.htm 00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://hartfordhealthcare.org/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://hartfordhealthcare.org/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - ACQUISITIONS AND DISPOSALS Sheet http://hartfordhealthcare.org/role/AcquisitionsAndDisposals ACQUISITIONS AND DISPOSALS Notes 10 false false R11.htm 00000011 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://hartfordhealthcare.org/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://hartfordhealthcare.org/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 12 false false R13.htm 00000013 - Disclosure - SEGMENT INFORMATION Sheet http://hartfordhealthcare.org/role/SegmentInformation SEGMENT INFORMATION Notes 13 false false R14.htm 00000014 - Disclosure - SUBSEQUENT EVENTS Sheet http://hartfordhealthcare.org/role/SubsequentEvents SUBSEQUENT EVENTS Notes 14 false false R15.htm 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 15 false false R16.htm 00000016 - Disclosure - ACQUISITIONS AND DISPOSALS (Tables) Sheet http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsTables ACQUISITIONS AND DISPOSALS (Tables) Tables http://hartfordhealthcare.org/role/AcquisitionsAndDisposals 16 false false R17.htm 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies 17 false false R18.htm 00000018 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://hartfordhealthcare.org/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://hartfordhealthcare.org/role/GoingConcern 18 false false R19.htm 00000019 - Disclosure - SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details) Details 19 false false R20.htm 00000020 - Disclosure - ACQUISITIONS AND DISPOSALS (Details Narrative) Sheet http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative ACQUISITIONS AND DISPOSALS (Details Narrative) Details http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsTables 20 false false R21.htm 00000021 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://hartfordhealthcare.org/role/RelatedPartyTransactions 21 false false R22.htm 00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://hartfordhealthcare.org/role/SubsequentEvents 22 false false All Reports Book All Reports form10-q.htm hfus-20240131.xsd hfus-20240131_cal.xml hfus-20240131_def.xml hfus-20240131_lab.xml hfus-20240131_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 39 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "HFUS", "nsuri": "http://hartfordhealthcare.org/20240131", "dts": { "inline": { "local": [ "form10-q.htm" ] }, "schema": { "local": [ "hfus-20240131.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "hfus-20240131_cal.xml" ] }, "definitionLink": { "local": [ "hfus-20240131_def.xml" ] }, "labelLink": { "local": [ "hfus-20240131_lab.xml" ] }, "presentationLink": { "local": [ "hfus-20240131_pre.xml" ] } }, "keyStandard": 127, "keyCustom": 10, "axisStandard": 10, "axisCustom": 0, "memberStandard": 8, "memberCustom": 14, "hidden": { "total": 67, "http://fasb.org/us-gaap/2023": 62, "http://xbrl.sec.gov/dei/2023": 4, "http://hartfordhealthcare.org/20240131": 1 }, "contextCount": 90, "entityCount": 1, "segmentCount": 25, "elementCount": 248, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 339, "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://hartfordhealthcare.org/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://hartfordhealthcare.org/role/BalanceSheets", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-01-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R3": { "role": "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-01-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R4": { "role": "http://hartfordhealthcare.org/role/StatementsOfOperations", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-11-012024-01-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-11-012024-01-31", "name": "us-gaap:GrossProfit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R5": { "role": "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome", "longName": "00000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2023-11-012024-01-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-11-012024-01-31", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R6": { "role": "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit", "longName": "00000006 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit)", "shortName": "Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "AsOf2022-07-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-08-012022-10-31_us-gaap_RetainedEarningsMember", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://hartfordhealthcare.org/role/StatementsOfCashFlows", "longName": "00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R8": { "role": "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPolicies", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://hartfordhealthcare.org/role/GoingConcern", "longName": "00000009 - Disclosure - GOING CONCERN", "shortName": "GOING CONCERN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://hartfordhealthcare.org/role/AcquisitionsAndDisposals", "longName": "00000010 - Disclosure - ACQUISITIONS AND DISPOSALS", "shortName": "ACQUISITIONS AND DISPOSALS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://hartfordhealthcare.org/role/RelatedPartyTransactions", "longName": "00000011 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://hartfordhealthcare.org/role/CommitmentsAndContingencies", "longName": "00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://hartfordhealthcare.org/role/SegmentInformation", "longName": "00000013 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://hartfordhealthcare.org/role/SubsequentEvents", "longName": "00000014 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "15", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "HFUS:OrganizationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "HFUS:OrganizationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsTables", "longName": "00000016 - Disclosure - ACQUISITIONS AND DISPOSALS (Tables)", "shortName": "ACQUISITIONS AND DISPOSALS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "16", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "17", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:IncomeTaxExaminationDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:IncomeTaxExaminationDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://hartfordhealthcare.org/role/GoingConcernDetailsNarrative", "longName": "00000018 - Disclosure - GOING CONCERN (Details Narrative)", "shortName": "GOING CONCERN (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "18", "firstAnchor": { "contextRef": "AsOf2024-01-31", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R19": { "role": "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "longName": "00000019 - Disclosure - SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details)", "shortName": "SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "19", "firstAnchor": { "contextRef": "AsOf2022-08-01_custom_ShanghaiOverseaMember_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-08-01_custom_ShanghaiOverseaMember_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "longName": "00000020 - Disclosure - ACQUISITIONS AND DISPOSALS (Details Narrative)", "shortName": "ACQUISITIONS AND DISPOSALS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "AsOf2022-08-01_custom_ShanghaiOverseaMember_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2019-01-31_custom_ShanghaiLuoShengInternationalTradeLtdMember", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R21": { "role": "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000021 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "AsOf2024-01-31", "name": "us-gaap:AccountsPayableCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-07-31", "name": "us-gaap:AccountsPayableCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R22": { "role": "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative", "longName": "00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "From2023-08-01to2024-01-31", "name": "us-gaap:ProceedsFromRelatedPartyDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-02-012024-02-29_us-gaap_SubsequentEventMember", "name": "us-gaap:RevenueNotFromContractWithCustomer", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts payable, related parties", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r52", "r464" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related party receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r190", "r191" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r25", "r26", "r75", "r118", "r310", "r324", "r325" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r3", "r13", "r26", "r254", "r257", "r276", "r320", "r321", "r443", "r444", "r445", "r450", "r451", "r452" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r70", "r409", "r467" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r234", "r235", "r236", "r333", "r450", "r451", "r452", "r458", "r469" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r435" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r95", "r116", "r140", "r169", "r177", "r182", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r249", "r251", "r262", "r306", "r356", "r409", "r420", "r456", "r457", "r461" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r113", "r119", "r140", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r249", "r251", "r262", "r409", "r456", "r457", "r461" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Non-current Assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r140", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r249", "r251", "r262", "r456", "r457", "r461" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-current Assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r435" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r247", "r402", "r405" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r42", "r44", "r247", "r402", "r405" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r247" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business acquisition, percentage of voting interests acquired", "verboseLabel": "Business acquired ownership interest", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r43" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposals" ], "lang": { "en-us": { "role": { "label": "ACQUISITIONS AND DISPOSALS", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r93", "r248" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r30", "r115", "r396" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r30", "r83", "r138" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in Cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r83" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r23", "r53", "r307", "r342" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r91", "r198", "r199", "r394", "r455" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r410", "r411", "r412", "r414", "r415", "r416", "r417", "r450", "r451", "r458", "r466", "r469" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r69" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r69", "r343" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r69", "r343", "r362", "r469", "r470" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock - $0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of January 31, 2024 and July 31, 2023.", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r69", "r309", "r409" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total Comprehensive (loss) income", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r27", "r122", "r124", "r132", "r302", "r317" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of revenue - Related Party", "verboseLabel": "Cost of revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r79", "r140", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r262", "r456" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument interest rate effective percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r22", "r48", "r210", "r275" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument, interest rate, stated percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r22", "r209" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r8", "r35" ] }, "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Gain on disposal of the subsidiary", "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation." } } }, "auth_ref": [ "r55", "r56", "r57" ] }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discontinued Operations, Disposed of by Sale [Member]", "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results." } } }, "auth_ref": [ "r6" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r111" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r2", "r54", "r63", "r89" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of business unit, consideration", "verboseLabel": "Consideration", "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation." } } }, "auth_ref": [] }, "HFUS_DisposalGroupIncludingDiscontinuedOperationContractLiiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "DisposalGroupIncludingDiscontinuedOperationContractLiiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Contract liabilities", "documentation": "Disposal group including discontinued operation contract liiabilities current." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r54", "r63", "r88", "r89" ] }, "HFUS_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities, current and noncurrent", "documentation": "Disposal group including discontinued operation lease liabilities." } } }, "auth_ref": [] }, "HFUS_DisposalGroupIncludingDiscontinuedOperationNetAssetsOfSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "DisposalGroupIncludingDiscontinuedOperationNetAssetsOfSubsidiary", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest", "documentation": "Disposal group, including discontinued operation, net assets of the subsidiary." } } }, "auth_ref": [] }, "HFUS_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling interest", "documentation": "Disposal group, including discontinued operation, noncontrolling interest." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Other assets", "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r54", "r63", "r88", "r89" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current payable", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current", "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r54", "r63", "r88", "r89" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other liabilities", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities", "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r2", "r54", "r63", "r89" ] }, "HFUS_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsSold": { "xbrltype": "percentItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsSold", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of voting interests sold", "documentation": "Disposal group including discontinued operation percentage of voting interests sold." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaid and Other current receivables", "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current", "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r54", "r63", "r88", "r89" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment - Net", "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r54", "r63", "r88", "r89" ] }, "HFUS_DisposalGroupIncludingDiscontinuedOperationRelatedPartyLoanAndPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "DisposalGroupIncludingDiscontinuedOperationRelatedPartyLoanAndPayable", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Related party loan and payables", "documentation": "Disposal group including discontinued operation related party loan and payable.", "label": "DisposalGroupIncludingDiscontinuedOperationRelatedPartyLoanAndPayable" } } }, "auth_ref": [] }, "HFUS_DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Related party receivable", "documentation": "Disposal group, including discontinued operation, related party receivable.", "label": "Disposal group, including discontinued operation, related party receivable" } } }, "auth_ref": [] }, "HFUS_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetsOperatingLease": { "xbrltype": "monetaryItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetsOperatingLease", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "ROU assets-Operating lease", "documentation": "Disposal group including discontinued operation right of use assets operating lease." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group." } } }, "auth_ref": [ "r402", "r405" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r434" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r432", "r434", "r435" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r433" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r421" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r434" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r434" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r436" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r424" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per common share, basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r133", "r148", "r149", "r150", "r151", "r152", "r156", "r158", "r160", "r161", "r162", "r163", "r260", "r261", "r303", "r318", "r398" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net (loss) income per common share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per common share, diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r133", "r148", "r149", "r150", "r151", "r152", "r158", "r160", "r161", "r162", "r163", "r260", "r261", "r303", "r318", "r398" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r264" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r427" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r423" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r423" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r440" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r423" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r437" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r435" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r423" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r423" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r423" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r423" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r438" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r109", "r126", "r127", "r128", "r143", "r144", "r145", "r147", "r153", "r155", "r164", "r196", "r197", "r212", "r234", "r235", "r236", "r244", "r245", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r265", "r267", "r268", "r269", "r270", "r272", "r276", "r320", "r321", "r322", "r333", "r387" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r192", "r193", "r194" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity ownership percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r192" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_GainOrLossOnSaleOfStockInSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainOrLossOnSaleOfStockInSubsidiary", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 }, "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gain on disposal of subsidiary", "negatedLabel": "Disposal of subsidiaries", "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries." } } }, "auth_ref": [ "r446", "r447", "r448", "r463" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross Profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r78", "r140", "r169", "r176", "r181", "r184", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r262", "r400", "r456" ] }, "HFUS_HangzhouHartfordComprehensiveHealthManagementLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "HangzhouHartfordComprehensiveHealthManagementLtdMember", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Hangzhou Hartford Comprehensive Health Management Ltd [Member]", "documentation": "Hangzhou Hartford Comprehensive Health Management Ltd [Member]" } } }, "auth_ref": [] }, "HFUS_HangzhouLongjingQiaoFuVacationHotelCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "HangzhouLongjingQiaoFuVacationHotelCoLtdMember", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. [Member]", "documentation": "Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd [Member]" } } }, "auth_ref": [] }, "HFUS_HartfordHotelInvestmentIncMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "HartfordHotelInvestmentIncMember", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Hartford Hotel Investment Inc [Member]", "documentation": "Hartford Hotel Investment Inc [Member]" } } }, "auth_ref": [] }, "HFUS_HartfordInternationalEducationTechnologyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "HartfordInternationalEducationTechnologyCoLtdMember", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Hartford International Education Technology Co., Ltd [Member]", "documentation": "Hartford International Education Technology Co., Ltd [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "(Loss) income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r76", "r98", "r169", "r176", "r181", "r184", "r304", "r314", "r400" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r402", "r405" ] }, "us-gaap_IncomeTaxExaminationDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationDescription", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income tax examination description", "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings." } } }, "auth_ref": [ "r41" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r102", "r107", "r154", "r155", "r173", "r239", "r246", "r319" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r125", "r237", "r238", "r240", "r241", "r242", "r243", "r327" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income taxes paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r31" ] }, "us-gaap_IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Related party receivables and payables", "label": "Increase (Decrease) in Broker-Dealer Related Receivables (Payables), Net", "documentation": "The increase (decrease) during the reporting period in receivables or payables that result from buying and selling securities for the firm's own account or from acting as an agent or intermediary in the sale of securities." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayable", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Other current payable", "label": "Increase (Decrease) in Other Accounts Payable", "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid and Other current receivables", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest expense, related party", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r49", "r101", "r129", "r172", "r274", "r372", "r418", "r468" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest (expense), net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r100" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r134", "r136", "r137" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unpaid principal", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r52", "r464" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r20", "r140", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r250", "r251", "r252", "r262", "r341", "r399", "r420", "r456", "r461", "r462" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r74", "r97", "r312", "r409", "r449", "r453", "r459" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r21", "r114", "r140", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r250", "r251", "r252", "r262", "r409", "r456", "r461", "r462" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "HFUS_MRLianyuSongMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "MRLianyuSongMember", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "MR Lianyu Song [Member]", "documentation": "MR Lianyu Song [Member]" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity ownership percentage", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "us-gaap_MultiemployerPlansLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MultiemployerPlansLineItems", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Multiemployer Plan [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r402", "r403", "r404", "r405", "r406", "r407", "r408" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r135" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r135" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r83", "r84", "r85" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit", "http://hartfordhealthcare.org/role/StatementsOfCashFlows", "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net (loss) income", "label": "Net (loss) income", "verboseLabel": "Net income (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r77", "r85", "r99", "r112", "r120", "r123", "r128", "r140", "r146", "r148", "r149", "r150", "r151", "r154", "r155", "r159", "r169", "r176", "r181", "r184", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r261", "r262", "r315", "r364", "r385", "r386", "r400", "r418", "r456" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Disposal of subsidiary", "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders." } } }, "auth_ref": [ "r12", "r36", "r94" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r45", "r212", "r450", "r451", "r452", "r469" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Other income (expense), net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r81" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related party loan and payables", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r19" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating Loss", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r169", "r176", "r181", "r184", "r400" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "HFUS_OrganizationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "OrganizationPolicyTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Organization", "documentation": "Organization [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation adjustments", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation adjustment", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4", "r5", "r263", "r271" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r14", "r16", "r121", "r124", "r131", "r265", "r266", "r272", "r301", "r316", "r443", "r444" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive (loss) income, net of income tax" } } }, "auth_ref": [] }, "us-gaap_OtherIncomeAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndExpensesAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Income (Expense)" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense), net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r82" ] }, "us-gaap_OtherNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNotesPayable", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other current payable", "documentation": "Amount of long-term notes payable classified as other." } } }, "auth_ref": [ "r17", "r96", "r465" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Receivables", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r117", "r351" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r434" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r428" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r429" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r68", "r211" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r68", "r343" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r68", "r211" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r68", "r343", "r362", "r469", "r470" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r68", "r308", "r409" ] }, "us-gaap_PrepaidAdvertising": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidAdvertising", "crdr": "debit", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prepaid advertising", "documentation": "Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r397", "r401", "r454" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid and Other current receivables", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r442" ] }, "HFUS_ProceedsFromAdvancesFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "ProceedsFromAdvancesFromRelatedParties", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Advances from related parties", "documentation": "Proceeds from advance from related parties." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows", "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds of related party notes payable", "verboseLabel": "Proceeds from related party debt", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r28" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r9", "r305", "r313", "r409" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r221", "r280", "r281", "r336", "r337", "r338", "r339", "r340", "r361", "r363", "r392" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r141", "r142", "r280", "r281", "r282", "r283", "r336", "r337", "r338", "r339", "r340", "r361", "r363", "r392" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r280", "r281", "r460" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r367", "r368", "r371" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r221", "r280", "r281", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r336", "r337", "r338", "r339", "r340", "r361", "r363", "r392", "r460" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r277", "r278", "r279", "r281", "r284", "r329", "r330", "r331", "r369", "r370", "r371", "r390", "r391" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payment of related party notes payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r29" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r71", "r92", "r311", "r323", "r325", "r328", "r344", "r409" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r109", "r143", "r144", "r145", "r147", "r153", "r155", "r196", "r197", "r234", "r235", "r236", "r244", "r245", "r253", "r255", "r256", "r258", "r259", "r320", "r322", "r333", "r469" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r108", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r395" ] }, "us-gaap_RevenueNotFromContractWithCustomer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueNotFromContractWithCustomer", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advanced payment from contracted customers", "documentation": "Amount of revenue that is not accounted for under Topic 606." } } }, "auth_ref": [ "r441" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/StatementsOfOperations", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue - Related Party", "verboseLabel": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r130", "r140", "r170", "r171", "r175", "r179", "r180", "r186", "r188", "r189", "r195", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r262", "r304", "r456" ] }, "HFUS_SHQiahongMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "SHQiahongMember", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "SHQiahong [Member]", "documentation": "SHQiahong [Member]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r42", "r44", "r247" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r11", "r37", "r38", "r39", "r40" ] }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY", "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r10", "r15", "r18", "r54", "r58", "r59", "r60", "r61", "r62", "r64", "r65", "r66", "r90" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r192", "r193", "r194" ] }, "us-gaap_ScheduleOfMultiemployerPlansTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMultiemployerPlansTable", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "lang": { "en-us": { "role": { "label": "Multiemployer Plan [Table]", "documentation": "Disclosure of information about multiemployer plan." } } }, "auth_ref": [ "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r402", "r403", "r404", "r405", "r406", "r407", "r408" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r50", "r51", "r367", "r368", "r371" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r422" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r426" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r425" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r430" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/SegmentInformation" ], "lang": { "en-us": { "role": { "label": "SEGMENT INFORMATION", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r165", "r166", "r167", "r168", "r169", "r174", "r178", "r182", "r183", "r184", "r185", "r186", "r187", "r189" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r80" ] }, "HFUS_ShanghaiDubianAssetsManagementLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "ShanghaiDubianAssetsManagementLtdMember", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shanghai Dubian Assets Management Ltd [Member]", "documentation": "Shanghai Dubian Assets Management Ltd [Member]" } } }, "auth_ref": [] }, "HFUS_ShanghaiHdfdZhongliEducationTechnologyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "ShanghaiHdfdZhongliEducationTechnologyCoLtdMember", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shanghai HDFD Zhongli Education Technology Co Ltd [Member]", "documentation": "Shanghai Hdfd Zhongli Education Technology Co Ltd [Member]" } } }, "auth_ref": [] }, "HFUS_ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd. [Member]", "documentation": "Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd. [Member]" } } }, "auth_ref": [] }, "HFUS_ShanghaiLuoShengInternationalTradeLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "ShanghaiLuoShengInternationalTradeLtdMember", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shanghai Luo Sheng International Trade Ltd. [Member]", "documentation": "Shanghai Luo Sheng International Trade Ltd. [Member]" } } }, "auth_ref": [] }, "HFUS_ShanghaiOverseaChineseCultureMediaLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "ShanghaiOverseaChineseCultureMediaLtdMember", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shanghai Oversea Chinese Culture Media Ltd [Member]", "documentation": "Shanghai Oversea Chinese Culture Media Ltd [Member]" } } }, "auth_ref": [] }, "HFUS_ShanghaiOverseaMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "ShanghaiOverseaMember", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsAndDisposalsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shanghai Oversea [Member]", "documentation": "Shanghai Oversea [Member]" } } }, "auth_ref": [] }, "HFUS_ShanghaiQiaoGardenInternationalTravelAgencyMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "ShanghaiQiaoGardenInternationalTravelAgencyMember", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shanghai Qiao Garden International Travel Agency [Member]", "documentation": "Shanghai Qiao Garden International Travel Agency [Member]" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r86", "r139" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r431" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r24", "r109", "r126", "r127", "r128", "r143", "r144", "r145", "r147", "r153", "r155", "r164", "r196", "r197", "r212", "r234", "r235", "r236", "r244", "r245", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r265", "r267", "r268", "r269", "r270", "r272", "r276", "r320", "r321", "r322", "r333", "r387" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r143", "r144", "r145", "r164", "r288", "r326", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r343", "r346", "r347", "r348", "r349", "r350", "r352", "r353", "r354", "r355", "r357", "r358", "r359", "r360", "r361", "r363", "r365", "r366", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r387", "r413" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r143", "r144", "r145", "r164", "r288", "r326", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r343", "r346", "r347", "r348", "r349", "r350", "r352", "r353", "r354", "r355", "r357", "r358", "r359", "r360", "r361", "r363", "r365", "r366", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r387", "r413" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders\u2019 Deficit", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r69", "r72", "r73", "r87", "r345", "r362", "r388", "r389", "r409", "r420", "r449", "r453", "r459", "r469" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Deficit)" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/StatementOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Balance,", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r45", "r46", "r47", "r109", "r110", "r127", "r143", "r144", "r145", "r147", "r153", "r196", "r197", "r212", "r234", "r235", "r236", "r244", "r245", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r265", "r267", "r272", "r276", "r321", "r322", "r332", "r345", "r362", "r388", "r389", "r393", "r419", "r449", "r453", "r459", "r469" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r273", "r286" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r273", "r286" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r273", "r286" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r273", "r286" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r273", "r286" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r285", "r287" ] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/GoingConcern" ], "lang": { "en-us": { "role": { "label": "GOING CONCERN", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r67" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "HFUS_TwoIndividualInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://hartfordhealthcare.org/20240131", "localname": "TwoIndividualInvestorsMember", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Individual Investors [Member]", "documentation": "Two Individual Investors [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r32", "r33", "r34", "r103", "r104", "r105", "r106" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding - diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r157", "r162" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding - basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r156", "r162" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r439" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1B" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r396": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r401": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r402": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r405": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r407": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r408": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r409": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r410": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r412": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r417": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r418": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r419": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r420": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r421": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r422": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r423": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r425": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r427": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r428": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r429": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r430": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r431": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r432": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r433": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r434": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r435": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r436": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r438": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r439": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r440": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(g))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r464": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r465": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r466": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r467": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r468": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r469": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r470": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 40 0001493152-24-009931-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-009931-xbrl.zip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form10-q_htm.xml IDEA: XBRL DOCUMENT 0001482554 2023-08-01 2024-01-31 0001482554 2024-03-14 0001482554 2024-01-31 0001482554 2023-07-31 0001482554 us-gaap:RelatedPartyMember 2024-01-31 0001482554 us-gaap:RelatedPartyMember 2023-07-31 0001482554 2023-11-01 2024-01-31 0001482554 2022-11-01 2023-01-31 0001482554 2022-08-01 2023-01-31 0001482554 us-gaap:CommonStockMember 2023-07-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001482554 us-gaap:RetainedEarningsMember 2023-07-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-07-31 0001482554 us-gaap:CommonStockMember 2023-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001482554 us-gaap:RetainedEarningsMember 2023-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-10-31 0001482554 2023-10-31 0001482554 us-gaap:CommonStockMember 2022-07-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001482554 us-gaap:RetainedEarningsMember 2022-07-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-31 0001482554 us-gaap:NoncontrollingInterestMember 2022-07-31 0001482554 2022-07-31 0001482554 us-gaap:CommonStockMember 2022-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001482554 us-gaap:RetainedEarningsMember 2022-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2022-10-31 0001482554 2022-10-31 0001482554 us-gaap:CommonStockMember 2023-08-01 2023-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-08-01 2023-10-31 0001482554 us-gaap:RetainedEarningsMember 2023-08-01 2023-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-08-01 2023-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-08-01 2023-10-31 0001482554 2023-08-01 2023-10-31 0001482554 us-gaap:CommonStockMember 2023-11-01 2024-01-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-11-01 2024-01-31 0001482554 us-gaap:RetainedEarningsMember 2023-11-01 2024-01-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-11-01 2024-01-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-11-01 2024-01-31 0001482554 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001482554 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-08-01 2022-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2022-08-01 2022-10-31 0001482554 2022-08-01 2022-10-31 0001482554 us-gaap:CommonStockMember 2022-11-01 2023-01-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-01-31 0001482554 us-gaap:RetainedEarningsMember 2022-11-01 2023-01-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-11-01 2023-01-31 0001482554 us-gaap:NoncontrollingInterestMember 2022-11-01 2023-01-31 0001482554 us-gaap:CommonStockMember 2024-01-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0001482554 us-gaap:RetainedEarningsMember 2024-01-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-31 0001482554 us-gaap:NoncontrollingInterestMember 2024-01-31 0001482554 us-gaap:CommonStockMember 2023-01-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001482554 us-gaap:RetainedEarningsMember 2023-01-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-31 0001482554 us-gaap:NoncontrollingInterestMember 2023-01-31 0001482554 2023-01-31 0001482554 HFUS:HangzhouLongjingQiaoFuVacationHotelCoLtdMember 2020-12-31 0001482554 HFUS:ShanghaiQiaoGardenInternationalTravelAgencyMember 2020-12-31 0001482554 HFUS:ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember 2019-07-24 0001482554 HFUS:ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember 2020-03-23 0001482554 HFUS:ShanghaiHdfdZhongliEducationTechnologyCoLtdMember 2021-08-31 0001482554 HFUS:TwoIndividualInvestorsMember 2021-08-31 0001482554 HFUS:HartfordInternationalEducationTechnologyCoLtdMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:ShanghaiOverseaMember 2022-08-01 0001482554 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:ShanghaiOverseaMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2022-08-01 0001482554 HFUS:HangzhouHartfordComprehensiveHealthManagementLtdMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:ShanghaiOverseaMember 2022-08-01 0001482554 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:ShanghaiOverseaMember HFUS:HangzhouHartfordComprehensiveHealthManagementLtdMember 2022-08-01 0001482554 HFUS:ShanghaiDubianAssetsManagementLtdMember 2023-08-01 2024-01-31 0001482554 HFUS:ShanghaiLuoShengInternationalTradeLtdMember 2019-01-31 0001482554 HFUS:ShanghaiLuoShengInternationalTradeLtdMember 2022-08-01 0001482554 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:ShanghaiOverseaMember 2022-08-01 0001482554 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember HFUS:ShanghaiOverseaMember 2022-08-01 2022-08-01 0001482554 HFUS:SHQiahongMember 2024-01-31 0001482554 HFUS:SHQiahongMember 2023-07-31 0001482554 HFUS:ShanghaiOverseaChineseCultureMediaLtdMember 2024-01-31 0001482554 HFUS:ShanghaiOverseaChineseCultureMediaLtdMember 2023-07-31 0001482554 HFUS:HartfordHotelInvestmentIncMember 2024-01-31 0001482554 HFUS:MRLianyuSongMember us-gaap:SubsequentEventMember 2024-02-22 2024-02-23 0001482554 HFUS:MRLianyuSongMember us-gaap:SubsequentEventMember 2024-02-23 0001482554 HFUS:HartfordHotelInvestmentIncMember us-gaap:SubsequentEventMember 2024-03-01 2024-03-01 0001482554 us-gaap:SubsequentEventMember 2024-02-01 2024-02-29 0001482554 us-gaap:SubsequentEventMember 2024-02-29 iso4217:USD shares iso4217:USD shares pure iso4217:CNY false --07-31 Q2 0001482554 10-Q true 2024-01-31 2024 false 000-54439 HARTFORD GREAT HEALTH CORP. NV 51-0675116 8832 Glendon Way Rosemead CA 91770 (626) 321-1915 Yes Yes Non-accelerated Filer true true false false Common stock, par value $0.001 par value HFUS 100108000 8484 5793 282 280 964 964 9730 7037 597 730 597 730 10327 7767 4440337 4367194 131835 130279 4572172 4497473 4572172 4497473 0.001 0.001 5000000 5000000 0 0 0 0 0.001 0.001 300000000 300000000 100108000 100108000 100108 100108 2173521 2173521 -7049170 -7003717 213696 240382 -4561845 -4489706 10327 7767 62443 62443 55505 55505 6938 6938 21942 21362 42134 76010 21942 21362 42134 76010 -15004 -21362 -35196 -76010 -5067 -4089 -10331 -8178 539230 74 74 -91 -4993 -4089 -10257 530961 -19997 -25451 -45453 454951 -19997 -25451 -45453 454951 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.00 0.00 100108000 100108000 100108000 100108000 100108000 100108000 100108000 100108000 -19997 -25451 -45453 454951 -123853 -322644 -26686 23289 -123853 -322644 -26686 23289 -143850 -348095 -72139 478240 100108000 100108 2173521 -7003717 240382 -4489706 -25456 -25456 97167 97167 100108000 100108 2173521 -7029173 337549 -4417995 -19997 -19997 -123853 -123853 100108000 100108 2173521 -7049170 213696 -4561845 100108000 100108 2173521 -7400620 -16742 -1288916 -6432649 100108000 100108 2173521 -7400620 -16742 -1288916 -6432649 480402 480402 1307586 1307586 345933 -18670 327263 100108000 100108 2173521 -6920218 329191 -4317398 -25451 -25451 -25451 -25451 -322644 -322644 100108000 100108 2173521 -6945669 6547 -4665493 100108000 100108 2173521 -6945669 6547 -4665493 -45453 454951 136 539230 -827 -10330 -26955 694 -6631 -34293 -63128 36000 60000 971 36971 60000 13 -1524 2691 -4652 5793 15227 8484 10575 <p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zHW4E4t8i0b8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_82B_z77mcrnyY0C5">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. The financial statements and notes are the responsibility of the Company’s management. These accounting policies conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied in the preparation of the financial statements. This disclosure should be read in conjunction with our audited financial statements for the year ended July 31, 2023, including footnotes, contained in our Annual Report on Form 10-K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--OrganizationPolicyTextBlock_zlTfKr0eoFua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zq7kfweUDsA3">Organization</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20201231__us-gaap--BusinessAcquisitionAxis__custom--HangzhouLongjingQiaoFuVacationHotelCoLtdMember_zESXEdm8RnQ4" title="Business acquisition, percentage of voting interests acquired">60</span> percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Health Management, Ltd. (“HFSH”) and its <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20201231__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiQiaoGardenInternationalTravelAgencyMember_zyMdTjiElbad" title="Business acquisition, percentage of voting interests acquired">90</span> percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190724__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember_zSjLyrB1Lw3h" title="Equity ownership percentage"><span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200323__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember_zJCCpOjE334f" title="Equity ownership percentage">100</span></span>% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”). Gelinke temporally ceased its operations by the end of August 2021. On August 31, 2021, PDHJ established one <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210831__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiHdfdZhongliEducationTechnologyCoLtdMember_z6KxuazUm4Tf" title="Equity ownership percentage">96</span>% owned subsidiary, Shanghai HDFD Zhongli Education Technology Co., Ltd. (“Zhongli”), two individual investors hold the remaining <span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210831__srt--OwnershipAxis__custom--TwoIndividualInvestorsMember_zZqvZAcu9Z17" title="Equity ownership percentage">4</span>% ownership.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impacted by the government regulation implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, to avoid further operation losses, on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell <span id="xdx_906_ecustom--DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsSold_iI_pid_dp_uPure_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__srt--OwnershipAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zTFc6LojuPb6" title="Percentage of voting interests sold">90</span> percent ownership of HF Int’l Education and its subsidiaries for $<span id="xdx_90A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zVyJDt443oN2" title="Sale of business unit, consideration">900</span> (RMB <span id="xdx_90E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_uRMB_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zVgmyHKsBaod" title="Sale of business unit, consideration">5,850</span>). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell <span id="xdx_902_ecustom--DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsSold_iI_pid_dp_uPure_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__srt--OwnershipAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_zejWVc9F6BB5" title="Percentage of voting interests sold">100</span> percent ownership of HZHF and its subsidiaries for $<span id="xdx_90E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_z46tjEHI60I1" title="Sale of business unit, consideration">1,000</span> (RMB <span id="xdx_90E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_uRMB_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_zHrDBZLEI2J5" title="Sale of business unit, consideration">6,500</span>). See Note 3 Acquisitions and Disposals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 10, 2024, HFSH changed its legal name from Shanghai Hartford Health Management, Ltd. to Hartford ZY Culture Media (Shanghai) Co., Ltd., hereon refer to as “HFZY”. and started to deliver media and advertisement services. HFZY mainly engage in social media advertising business on mainstream social media platforms such as Tik Tok, Toutiao, Kwai, RED, WeChat, and more. As an advertising partner of China’s major social media platforms, it provides customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. HFZY is one of the total solution advertising providers for domestic social media industry in China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z6Nv5IHWEKpi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zohUt0wBFoTe">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zomW1qlG0WY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zoQHWAVfNFBe">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zj2kylryU5D7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z90i9WwBxi54">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20230801__20240131_zucn0TsnOSr7" title="Income tax examination description">The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government</span>. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zyfTuZqguNa1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zbrDwjZ5YAR8">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is developing business plan to provide customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. Most of the advertising revenue will be generated by placing ad products on Tik Tok, Toutiao, Kwai, RED, WeChat, and other third-party affiliated websites and mobile applications. The revenues from the display of impression-based ads will be recognized in the contracted period in which the impressions are delivered. The Company will also generate revenue from the delivery of certain services, such as the creation and delivery of ads that appear on third-party publishers’ websites and social platforms. The Company recognizes revenues from these services in the period in which the service is completed. During current reporting period, the Company generated $<span id="xdx_90D_eus-gaap--Revenues_c20230801__20240131__us-gaap--RelatedPartyTransactionAxis__custom--ShanghaiDubianAssetsManagementLtdMember_zYeKf80I8Rcb" title="Revenues">62,443</span> revenue from designing, making, and placing video advertising for our related party customers, primarily Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the past years, the company’s main operations were focusing on Early childhood education services and Hospitality services. Impacted by the Covid-19 pandemic and Chinese regulation on education industry, both early childhood education services and hospitality services have been sold on August 1 2022. Thus, there was no revenue recognized for the three and six months ended January 31, 2023. See Note 3 Acquisitions and Disposals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKApF1YdbHY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zkSWn9j9N1Hb">Recent Accounting Pronouncements</span></b>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Recently not yet adopted accounting pronouncements </span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new guidance requires enhanced disclosures about income tax expenses. The Company is required to adopt this guidance in the first quarter of the fiscal year 2026. Early adoption is permitted on a prospective basis. We are currently evaluating the impact of this ASU on our annual income tax disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new guidance requires enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for its annual reporting in fiscal year 2025 and for interim period reporting beginning the first quarter of fiscal year 2026 on a retrospective basis. Early adoption is permitted. We are currently evaluating the impact of this ASU on our segment disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.</span></p> <p id="xdx_855_z2fNwF0WjI3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--OrganizationPolicyTextBlock_zlTfKr0eoFua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zq7kfweUDsA3">Organization</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20201231__us-gaap--BusinessAcquisitionAxis__custom--HangzhouLongjingQiaoFuVacationHotelCoLtdMember_zESXEdm8RnQ4" title="Business acquisition, percentage of voting interests acquired">60</span> percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Health Management, Ltd. (“HFSH”) and its <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20201231__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiQiaoGardenInternationalTravelAgencyMember_zyMdTjiElbad" title="Business acquisition, percentage of voting interests acquired">90</span> percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190724__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember_zSjLyrB1Lw3h" title="Equity ownership percentage"><span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200323__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember_zJCCpOjE334f" title="Equity ownership percentage">100</span></span>% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”). Gelinke temporally ceased its operations by the end of August 2021. On August 31, 2021, PDHJ established one <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210831__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiHdfdZhongliEducationTechnologyCoLtdMember_z6KxuazUm4Tf" title="Equity ownership percentage">96</span>% owned subsidiary, Shanghai HDFD Zhongli Education Technology Co., Ltd. (“Zhongli”), two individual investors hold the remaining <span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210831__srt--OwnershipAxis__custom--TwoIndividualInvestorsMember_zZqvZAcu9Z17" title="Equity ownership percentage">4</span>% ownership.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impacted by the government regulation implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, to avoid further operation losses, on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell <span id="xdx_906_ecustom--DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsSold_iI_pid_dp_uPure_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__srt--OwnershipAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zTFc6LojuPb6" title="Percentage of voting interests sold">90</span> percent ownership of HF Int’l Education and its subsidiaries for $<span id="xdx_90A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zVyJDt443oN2" title="Sale of business unit, consideration">900</span> (RMB <span id="xdx_90E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_uRMB_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zVgmyHKsBaod" title="Sale of business unit, consideration">5,850</span>). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell <span id="xdx_902_ecustom--DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsSold_iI_pid_dp_uPure_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__srt--OwnershipAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_zejWVc9F6BB5" title="Percentage of voting interests sold">100</span> percent ownership of HZHF and its subsidiaries for $<span id="xdx_90E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_z46tjEHI60I1" title="Sale of business unit, consideration">1,000</span> (RMB <span id="xdx_90E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_uRMB_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_zHrDBZLEI2J5" title="Sale of business unit, consideration">6,500</span>). See Note 3 Acquisitions and Disposals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 10, 2024, HFSH changed its legal name from Shanghai Hartford Health Management, Ltd. to Hartford ZY Culture Media (Shanghai) Co., Ltd., hereon refer to as “HFZY”. and started to deliver media and advertisement services. HFZY mainly engage in social media advertising business on mainstream social media platforms such as Tik Tok, Toutiao, Kwai, RED, WeChat, and more. As an advertising partner of China’s major social media platforms, it provides customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. HFZY is one of the total solution advertising providers for domestic social media industry in China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.60 0.90 1 1 0.96 0.04 0.90 900 5850 1 1000 6500 <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z6Nv5IHWEKpi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zohUt0wBFoTe">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zomW1qlG0WY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zoQHWAVfNFBe">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zj2kylryU5D7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z90i9WwBxi54">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20230801__20240131_zucn0TsnOSr7" title="Income tax examination description">The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government</span>. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government <p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zyfTuZqguNa1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zbrDwjZ5YAR8">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is developing business plan to provide customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. Most of the advertising revenue will be generated by placing ad products on Tik Tok, Toutiao, Kwai, RED, WeChat, and other third-party affiliated websites and mobile applications. The revenues from the display of impression-based ads will be recognized in the contracted period in which the impressions are delivered. The Company will also generate revenue from the delivery of certain services, such as the creation and delivery of ads that appear on third-party publishers’ websites and social platforms. The Company recognizes revenues from these services in the period in which the service is completed. During current reporting period, the Company generated $<span id="xdx_90D_eus-gaap--Revenues_c20230801__20240131__us-gaap--RelatedPartyTransactionAxis__custom--ShanghaiDubianAssetsManagementLtdMember_zYeKf80I8Rcb" title="Revenues">62,443</span> revenue from designing, making, and placing video advertising for our related party customers, primarily Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the past years, the company’s main operations were focusing on Early childhood education services and Hospitality services. Impacted by the Covid-19 pandemic and Chinese regulation on education industry, both early childhood education services and hospitality services have been sold on August 1 2022. Thus, there was no revenue recognized for the three and six months ended January 31, 2023. See Note 3 Acquisitions and Disposals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 62443 <p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKApF1YdbHY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zkSWn9j9N1Hb">Recent Accounting Pronouncements</span></b>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Recently not yet adopted accounting pronouncements </span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new guidance requires enhanced disclosures about income tax expenses. The Company is required to adopt this guidance in the first quarter of the fiscal year 2026. Early adoption is permitted on a prospective basis. We are currently evaluating the impact of this ASU on our annual income tax disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new guidance requires enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for its annual reporting in fiscal year 2025 and for interim period reporting beginning the first quarter of fiscal year 2026 on a retrospective basis. Early adoption is permitted. We are currently evaluating the impact of this ASU on our segment disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.</span></p> <p id="xdx_803_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zsxEH8aL02Nd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2. <span id="xdx_82D_z3k8IiGjVJV3">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, Hartford Great Health Corp. has incurred losses since inception, resulting in an accumulated deficit of $<span id="xdx_902_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240131_z2eseqVc3fr9" title="Accumulated deficit">7,049,170</span> as of January 31, 2024. This condition  raises substantial doubt about the ability of Hartford Great Health Corp. to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to Hartford Great Health Corp., and ultimately achieving profitable operations. Management believes that Hartford Great Health Corp.’s business plan provides it with an opportunity to continue as a going concern. However, management cannot provide assurance that Hartford Great Health Corp. will meet its objectives and be able to continue in operation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of Hartford Great Health Corp. to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -7049170 <p id="xdx_807_eus-gaap--BusinessCombinationDisclosureTextBlock_zGwFnDjJl8N9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3. <span id="xdx_822_zC7JKFa9bK03">ACQUISITIONS AND DISPOSALS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2019, HFSH entered agreements to acquire <span id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20190131__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiLuoShengInternationalTradeLtdMember_zvihULrrokTi" title="Business acquired ownership interest">100</span> percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). On August 1, 2022, HFSH decided to withdraw from the agreement entered in January 2019 to acquire <span id="xdx_90F_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20220801__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiLuoShengInternationalTradeLtdMember_zlfqCmn6zUCf" title="Business acquired ownership interest">100</span> percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). There was no penalty levied or to be levied due to delayed execution or inexecution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impacted by the government regulation newly implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, the Company’s business hasn’t been developed as planned and occurred significant loss from the early child education practice. To avoid further operation losses, subsequently on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell <span id="xdx_907_ecustom--DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsSold_iI_pid_dp_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__srt--OwnershipAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zbGbFbFXpp58" title="Percentage of voting interests sold">90</span> percent ownership of HF Int’l Education and its subsidiaries for $<span id="xdx_907_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_z93GmMv9snkf" title="Sale of business unit, consideration">900</span> (RMB <span id="xdx_90F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_uRMB_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zJcUnVDFOsxc" title="Sale of business unit, consideration">5,850</span>). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell <span id="xdx_909_ecustom--DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsSold_iI_pid_dp_uPure_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__srt--OwnershipAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_z7uOWmdYoLO6" title="Percentage of voting interests sold">100</span> percent ownership of HZHF and its subsidiaries for $<span id="xdx_901_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_z2XUbzmPFnwj" title="Sale of business unit, consideration">1,000</span> (RMB <span id="xdx_901_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_uRMB_c20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember__dei--LegalEntityAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_zrZvI3pMMS43" title="Sale of business unit, consideration">6,500</span>).</span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zUwK13MqXs48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zkaZf3WG09ke">SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>Net assets (liabilities) disposed of:</td><td> </td> <td colspan="2" id="xdx_492_20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember_zN7mojkS6tl9"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_zcMB3Ge8Onpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Cash and cash equivalents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,938</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_z3ru28HkHUtl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid and Other current receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,532</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable_iI_zrR8Jp5gyLV" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Related party receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">428,519</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_iI_zYYH7kL9k6ej" style="vertical-align: bottom; background-color: White"> <td>Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">305,124</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_iI_zcy8Vu6teBn9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment - Net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">582,707</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetsOperatingLease_iI_zenIxscA4KN" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">ROU assets-Operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,836,698</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_iI_zFLEso70wSC6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">296,218</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DisposalGroupIncludingDiscontinuedOperationRelatedPartyLoanAndPayable_iI_zuoAtdYT7Zz4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Related party loan and payables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,321,549</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationContractLiiabilitiesCurrent_iI_z5qBJajtf2Kj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Contract liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(547,906</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities_iI_zu7mhvNmYC58" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Lease liabilities, current and noncurrent</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,715,688</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iNI_di_zgGW3kNfKt8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other current payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(401,782</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_iNI_di_zWugIc9kClW9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(357,796</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_iI_z1SmGupmWb6e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Noncontrolling interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,307,586</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationNetAssetsOfSubsidiary_iI_zEvYdWah9mMi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(537,399</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_zPkftO61E1T5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Consideration</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,831</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Gain on disposal of the subsidiaries</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_c20220801__20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember_zA97Zn2SnSvj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gain on disposal of the subsidiary">(539,230</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A0_z5HALFqXTav2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 0.90 900 5850 1 1000 6500 <p id="xdx_89B_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zUwK13MqXs48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zkaZf3WG09ke">SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>Net assets (liabilities) disposed of:</td><td> </td> <td colspan="2" id="xdx_492_20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember_zN7mojkS6tl9"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_zcMB3Ge8Onpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Cash and cash equivalents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,938</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_z3ru28HkHUtl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid and Other current receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,532</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable_iI_zrR8Jp5gyLV" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Related party receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">428,519</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_iI_zYYH7kL9k6ej" style="vertical-align: bottom; background-color: White"> <td>Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">305,124</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_iI_zcy8Vu6teBn9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment - Net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">582,707</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetsOperatingLease_iI_zenIxscA4KN" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">ROU assets-Operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,836,698</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_iI_zFLEso70wSC6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">296,218</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DisposalGroupIncludingDiscontinuedOperationRelatedPartyLoanAndPayable_iI_zuoAtdYT7Zz4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Related party loan and payables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,321,549</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationContractLiiabilitiesCurrent_iI_z5qBJajtf2Kj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Contract liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(547,906</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities_iI_zu7mhvNmYC58" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Lease liabilities, current and noncurrent</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,715,688</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iNI_di_zgGW3kNfKt8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other current payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(401,782</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_iNI_di_zWugIc9kClW9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(357,796</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_iI_z1SmGupmWb6e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Noncontrolling interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,307,586</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationNetAssetsOfSubsidiary_iI_zEvYdWah9mMi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(537,399</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_zPkftO61E1T5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Consideration</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,831</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Gain on disposal of the subsidiaries</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_c20220801__20220801__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ShanghaiOverseaMember__us-gaap--DisposalGroupClassificationAxis__us-gaap--DiscontinuedOperationsDisposedOfBySaleMember_zA97Zn2SnSvj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gain on disposal of the subsidiary">(539,230</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> 4938 45532 428519 305124 582707 2836698 296218 -1321549 -547906 -3715688 401782 357796 1307586 -537399 1831 -539230 <p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zSE023LhWPh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4. <span id="xdx_82B_z4Kwuyz0AlWd">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Related Party Receivables</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HFUS had $<span id="xdx_904_eus-gaap--OtherReceivables_iI_c20240131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zjvIJ2QNWPH9" title="Receivables"><span id="xdx_908_eus-gaap--OtherReceivables_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUiuSkwJ2Bqg" title="Receivables">964</span></span> related party receivable as of both January 31, 2024 and July 31, 2023, due from SH Oversea in relation to the disposal consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Related Party Payables and loans</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 31, 2024 and July 31, 2023, amounts of $<span id="xdx_905_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20240131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SHQiahongMember_zPEm4AnxvAM3" title="Accounts payable related party">582,601</span> and $<span id="xdx_90C_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SHQiahongMember_zWTUZtCCjkAf" title="Accounts payable related party">586,236</span>, respectively, are payable to SH Qiaohong. The balances were mainly funding support from SH Qiaohong for operation. The funding support bears no interest and due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HFSH had payable balances to Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), an entity previously was managed by the same management team, in the amounts of $<span id="xdx_90E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20240131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiOverseaChineseCultureMediaLtdMember_zpKEcMY3CiGi" title="Accounts payable, related parties">3,321,300</span> and $<span id="xdx_90D_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiOverseaChineseCultureMediaLtdMember_z5QeuYjfTZO4" title="Accounts payable, related parties">3,291,324</span> as of January 31, 2024 and July 31, 2023, respectively. The payable is funding support from SH Oversea for operation, bears no interest and due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HFUS borrowed in form of a short-term loan at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HartfordHotelInvestmentIncMember_zwKAB2ikxOIa" title="Debt instrument, interest rate, stated percentage">5</span>% per annum from a related party, Hartford Hotel Investment Inc., an entity managed by the same management team. $<span id="xdx_90D_eus-gaap--InterestExpense_c20231101__20240131_z4NGQoJnpaoj" title="Interest expense, related party">5,067</span> and $<span id="xdx_90E_eus-gaap--InterestExpense_c20230801__20240131_zIQBiEIN9i03" title="Interest expense, related party">10,331</span> of interest expenses were recorded during the three and six months ended January 31, 2024, respectively. $<span id="xdx_905_eus-gaap--InterestExpense_c20221101__20230131_zbwCUBi2VgP4" title="Interest expense, related party">4,089</span> and $<span id="xdx_900_eus-gaap--InterestExpense_c20220801__20230131_zM7qmmFFpEG5" title="Interest expense, related party">8,178</span> of interest expenses were recorded during the three and six months ended January 31, 2023, respectively. As of January 31, 2024 and July 31, 2023, the unpaid principal and interest amount of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240131_zCCFc4ecmdNh" title="Unpaid principal">463,831</span> and $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20230731_zLiy4TpBVhBh" title="Unpaid principal">417,501</span>, respectively, will be due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining related party payable of $<span id="xdx_907_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20240131_z7nyau1mrJ3b">72,605</span> and $<span id="xdx_907_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20230731_zfoOEQ7ITqk3">72,133</span> as of January 31, 2024 and July 31, 2023, respectively, represents the unpaid portion of operating advances made to the Company by its main shareholder, Mr. Lianyue Song. These advances do not bear interest and are considered due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Other Related Party Transactions</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three and six months ended January 31, 2024, the Company generated $<span id="xdx_90D_eus-gaap--Revenues_c20230801__20240131_z5nDLF2vh0Qd" title="Revenues">62,443</span> revenue from designing, making, and placing video advertising for its related parties, primarily Shanghai DuBian Assets Management Ltd., which is managed by the Company’s major shareholder’s relatives. For the three and six months ended January 31, 2024, the Company incurred $<span id="xdx_90A_eus-gaap--CostOfRevenue_c20230801__20240131_zEgNJy2rKIrg" title="Cost of revenue">55,505</span> in costs related to revenue generation, primarily stemming from services provided by another related party, HF Int’l Education, a subsidiary of SH Oversea.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office space at Rosemead, CA is provided to Hartford Great Health Corp. at no cost by the sole executive officer. No provision for these costs has been included in these financial statements as the amounts are not material.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 964 964 582601 586236 3321300 3291324 0.05 5067 10331 4089 8178 463831 417501 72605 72133 62443 55505 <p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zJ6hFlJcijw1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5. <span id="xdx_828_zGk3JdikE311">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There has been no material contractual obligations and commitments as of January 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_800_eus-gaap--SegmentReportingDisclosureTextBlock_zjlOVfn9vaBf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6.<span id="xdx_823_zxQEVey1xhD5"> SEGMENT INFORMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification (“ASC”) 280, “Segment Reporting,” requires public companies to report financial and descriptive information about their reportable operating segments. We identify our operating segments based on how our chief operating decision maker internally evaluates separate financial information, business activities and management responsibility.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company used to operate in two reportable segments: hospitality (hotel and travel agency) and early childhood education industry in China in the past years. Due to the disposal of operating subsidiaries on August 1, 2022, we currently have one reportable segment for advertising services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_z3xBQbPMqSt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7. <span id="xdx_82D_zqqmtpBQ39db">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 855<i>, “Subsequent Events”</i>, the Company has evaluated subsequent events through the date of issuance of these unaudited financial statements and subsequent events were noted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 23, 2024, the Company borrowed $<span id="xdx_902_eus-gaap--ProceedsFromRelatedPartyDebt_c20240222__20240223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--MRLianyuSongMember_zuitu9bUfwJd" title="Proceeds from related party debt">85,000</span> from its major stockholder, Mr. Lianyue Song., in the form of a demand note at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240223__us-gaap--RelatedPartyTransactionAxis__custom--MRLianyuSongMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSZ7Bo3N73hj" title="Debt instrument interest rate effective percentage">5</span>% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 1, 2024, the Company returned $<span id="xdx_90A_eus-gaap--RepaymentsOfNotesPayable_c20240301__20240301__us-gaap--RelatedPartyTransactionAxis__custom--HartfordHotelInvestmentIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zg4uCoOaNJPe" title="Payment of related party notes payable">70,000</span>, a portion of the notes payable to the related party, Hartford Hotel Investment Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the month of February 2024, HFZY has entered advertising service contracts with ten customers and received approximately RMB <span id="xdx_903_eus-gaap--RevenueNotFromContractWithCustomer_pn4n6_uRMB_c20240201__20240229__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdFxj4o1eYZ7" title="Advanced payment from contracted customers">8.11</span> million (about USD<span id="xdx_90E_eus-gaap--RevenueNotFromContractWithCustomer_pn4n6_c20240201__20240229__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFhuAF3biua1" title="Advanced payment from contracted customers">1.13</span> million) as advanced payment from these customers. HFZY also entered a major supplier contract for advertising placement and prepaid RMB <span id="xdx_908_eus-gaap--PrepaidAdvertising_iI_pn4n6_uRMB_c20240229__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJMkUxkeeZWd" title="Prepaid advertising">7.70</span> million (about USD<span id="xdx_904_eus-gaap--PrepaidAdvertising_iI_pn4n6_c20240229__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3Ztl9KOGNU2" title="Prepaid advertising">1.07</span> million) to the supplier.</span></p> 85000 0.05 70000 8110000 1130000 7700000 1070000.00